https://curecurrent.com/trials/evaluating-the-t-cell-response-to-a-peptide-based-vaccine-in-patients-with-breast-cancer-38001https://curecurrent.com/trials/breast-cancer-risk-biomarkers-in-postmenopausal-women-38002https://curecurrent.com/trials/a-dose-finding-study-of-subcutaneous-herceptin-trastuzumab-in-healthy-male-volunteers-and-human-epidermal-growth-factor-38003https://curecurrent.com/trials/predict-the-risk-of-axillary-metastases-in-breast-cancer-patients-with-axillary-ultrasound-38004https://curecurrent.com/trials/a-study-of-pi3-kinase-inhibitor-gdc-0941-in-combination-with-paclitaxel-with-and-without-bevacizumab-or-trastuzumab-and-38005https://curecurrent.com/trials/abi-007-in-taxol-resistant-patients-with-metastatic-breast-cancer-38006https://curecurrent.com/trials/study-of-lurbinectedin-pm01183-in-combination-with-capecitabine-in-patients-with-metastatic-breast-cancer-mbc-pancreatic-38007https://curecurrent.com/trials/upper-limb-muscular-strengthening-in-the-rehabilitation-of-patients-submitted-to-the-breast-cancer-surgical-treatment-38008https://curecurrent.com/trials/short-term-fasting-during-chemotherapy-in-patients-with-gynecological-cancer-a-randomized-controlled-cross-over-trial-38009https://curecurrent.com/trials/irinotecan-and-cetuximab-in-treating-patients-with-metastatic-breast-cancer-38010https://curecurrent.com/trials/irinotecan-and-docetaxel-in-treating-patients-with-refractory-metastatic-breast-cancer-38011https://curecurrent.com/trials/citalopram-in-treating-postmenopausal-women-with-hot-flashes-38012https://curecurrent.com/trials/the-effect-of-reflexology-on-radiation-related-fatigue-in-breast-cancer-patients-38013https://curecurrent.com/trials/circulating-microrna-as-biomarker-of-cardiotoxicity-in-breast-cancer-38014https://curecurrent.com/trials/diagnostic-accuracy-and-safety-study-of-fes-pet-ct-in-assessment-of-er-status-of-recurrent-or-metastatic-breast-cancer-38015https://curecurrent.com/trials/erlotinib-and-gemcitabine-in-treating-patients-with-metastatic-breast-cancer-previously-treated-with-an-anthracycline-an-38016https://curecurrent.com/trials/docetaxel-capecitabine-and-bevacizumab-in-treating-patients-with-metastatic-breast-cancer-38017https://curecurrent.com/trials/a-trial-of-cdx-1401-in-combination-with-poly-iclc-and-pembrolizumab-in-previously-treated-advanced-solid-tumor-patients-38018https://curecurrent.com/trials/ly231514-plus-gemcitabine-in-treating-women-with-metastatic-breast-cancer-38019https://curecurrent.com/trials/docetaxel-and-carboplatin-in-treating-women-with-metastatic-breast-cancer-38020https://curecurrent.com/trials/ixabepilone-carboplatin-metastatic-breast-cancer-38021https://curecurrent.com/trials/ceramide-cream-in-treating-women-with-cutaneous-breast-cancer-38022https://curecurrent.com/trials/car-pnk-cell-immunotherapy-in-muc1-positive-relapsed-or-refractory-solid-tumor-38023https://curecurrent.com/trials/zoledronate-in-preventing-bone-loss-in-postmenopausal-women-who-are-receiving-letrozole-for-stage-i-stage-ii-or-stage-ii-38024https://curecurrent.com/trials/cabozantinib-for-metastatic-triple-negative-brca-38025https://curecurrent.com/trials/paclitaxel-poliglumex-and-capecitabine-in-treating-patients-with-metastatic-breast-cancer-38026https://curecurrent.com/trials/vinflunine-and-capecitabine-in-treating-patients-with-previously-treated-metastatic-breast-cancer-38027https://curecurrent.com/trials/fat-grafting-used-for-the-treatment-of-breast-cancer-related-lymphedema-in-china-38028https://curecurrent.com/trials/phase-i-ii-study-of-anti-mucin1-muc1-car-t-cells-for-patients-with-muc1-advanced-refractory-solid-tumor-38029https://curecurrent.com/trials/breast-cancer-chemoprevention-by-som230-an-igf-i-action-inhibitor-a-proof-of-principle-trial-38030https://curecurrent.com/trials/zactima-faslodex-trial-in-postmenopausal-advance-breast-cancer-patients-instead-of-zactima-faslodex-trial-38031https://curecurrent.com/trials/nurse-intervention-project-38032https://curecurrent.com/trials/dose-finding-study-of-empegfilgrastim-for-neutropenia-prophylaxis-in-patients-with-breast-cancer-38033https://curecurrent.com/trials/methylene-blue-intradermal-injection-for-sentinel-lymph-node-biopsy-for-breast-cancer-patients-38034https://curecurrent.com/trials/the-effect-of-art-therapy-on-physical-and-psychological-symptoms-of-breast-cancer-survivors-38035https://curecurrent.com/trials/registry-of-mastectomy-for-breast-cancer-risk-reduction-38036https://curecurrent.com/trials/adjuvant-endocrine-therapy-for-estrogen-receptor-beta-positive-triple-negative-breast-cancer-38037https://curecurrent.com/trials/lifestyle-intervention-for-high-risk-cancer-survivors-38038https://curecurrent.com/trials/web-based-study-for-cancer-survivors-38039https://curecurrent.com/trials/the-effect-of-acupoint-massotherapy-on-relieving-chemotherapy-induced-myelosupression-38040https://curecurrent.com/trials/maximal-respiratory-pressures-after-radiotherapy-38041https://curecurrent.com/trials/breast-mri-spectroscopy-38042https://curecurrent.com/trials/effectiveness-of-acupuncture-for-breast-cancer-related-lymphedema-38043https://curecurrent.com/trials/ultrasound-guided-percutaneous-microwave-ablation-for-breast-lesions-38044https://curecurrent.com/trials/rural-women-connecting-for-better-health-38045https://curecurrent.com/trials/phase-i-trial-68ga-nodaga-e-c-rgdyk-2-positron-emission-tomography-for-imaging-angiogenesis-in-primary-and-metastatic-tu-38046https://curecurrent.com/trials/neoadjuvant-treatment-of-docetaxel-anthracycline-and-cyclophosphamide-tac-versus-docetaxel-and-cyclophosphamide-tc-in-tr-38047https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-women-with-human-epidermal-growth-factor-receptor-her-2-positive-advanced-and-or-met-38048https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-pertuzumab-given-in-combination-with-trastuzumab-and-vinorelbine-in-participant-38049https://curecurrent.com/trials/iort-intra-operative-radiation-therapy-in-early-stage-breast-cancer-38050https://curecurrent.com/trials/pilot-3d-mammography-reader-study-to-assess-breast-cancer-detection-in-3d-versus-2d-digital-mammography-38051https://curecurrent.com/trials/the-efficacy-of-acupuncture-in-treating-chemotherapy-side-effects-in-breast-cancer-patients-38052https://curecurrent.com/trials/phase-ii-study-of-imatinib-mesylate-in-patients-with-life-threatening-malignant-rare-diseases-38053https://curecurrent.com/trials/pre-surgery-positron-emission-mammography-in-patients-with-newly-diagnosed-breast-cancer-38054https://curecurrent.com/trials/a-phase-2-randomized-double-blind-trial-evaluating-the-effects-of-chloroquine-in-breast-cancer-38055https://curecurrent.com/trials/breast-cancer-molecular-analysis-protocol-38056https://curecurrent.com/trials/reirradiation-with-concurrent-paclitaxel-for-breast-cancer-38057https://curecurrent.com/trials/multiple-oncological-serial-scans-study-38058https://curecurrent.com/trials/a-study-of-whole-brain-radiation-therapy-and-capecitabine-in-breast-cancer-participants-with-newly-diagnosed-brain-metas-38059https://curecurrent.com/trials/fatigue-in-breast-cancer-patients-undergoing-radiotherapy-esmart-mh-38060https://curecurrent.com/trials/intervention-to-improve-self-care-of-symptoms-in-breast-cancer-survivors-on-adjuvant-endocrine-therapy-38061https://curecurrent.com/trials/combination-chemotherapy-with-or-without-trastuzumab-in-treating-women-with-breast-cancer-38062https://curecurrent.com/trials/lapatinib-trastuzumab-in-addition-to-standard-neoadjuvant-breast-cancer-therapy-38063https://curecurrent.com/trials/nodal-staging-in-breast-cancer-with-mrl-38064https://curecurrent.com/trials/patient-factors-impacting-adherence-to-oral-chemotherapy-38065https://curecurrent.com/trials/preoperative-and-intraoperative-quantification-of-axillary-tumoral-load-38066https://curecurrent.com/trials/shandong-cancer-hospital-affiliated-to-shandong-university-38067https://curecurrent.com/trials/immediate-postmastectomy-breast-reconstruction-strattice-breast-38068https://curecurrent.com/trials/re-evaluation-of-tumor-samples-from-women-with-breast-cancer-with-the-in-vitro-diagnostic-kit-mammatypertm-38069https://curecurrent.com/trials/educational-program-in-younger-women-who-have-recently-finished-treatment-for-stage-i-or-stage-ii-breast-cancer-38070https://curecurrent.com/trials/protocol-for-women-at-increased-risk-of-developing-breast-cancer-38071https://curecurrent.com/trials/trial-of-eribulin-cyclophosphamide-or-docetaxel-cyclophosphamide-as-neoadjuvant-therapy-in-locally-advanced-her2-negativ-38072https://curecurrent.com/trials/adj-tc-herceptin-early-stage-breast-cancer-38073https://curecurrent.com/trials/prospective-observational-study-of-antitumor-activity-correlation-between-hormonal-therapy-and-expression-mirna100-38074https://curecurrent.com/trials/doxil-carboplatin-plus-her2-in-metastatic-breast-cancer-38075https://curecurrent.com/trials/improving-cancer-related-outcomes-in-shift-workers-38076https://curecurrent.com/trials/a-study-of-circulating-endothelial-cell-as-marker-for-avastin-bevacizumab-in-combination-with-docetaxel-plus-xeloda-cape-38077https://curecurrent.com/trials/a-study-of-xeloda-capecitabine-in-breast-cancer-patients-with-central-nervous-system-cns-progression-38078https://curecurrent.com/trials/a-study-of-prophylactic-treatment-for-hand-foot-syndrome-in-patients-treated-with-oral-xeloda-capecitabine-38079https://curecurrent.com/trials/a-study-of-the-safety-profile-of-first-line-avastin-bevacizumab-in-combination-with-paclitaxel-in-patients-with-locally-38080https://curecurrent.com/trials/an-observational-study-on-the-correlation-between-time-of-initiation-of-avastin-bevacizumab-treatment-and-progression-fr-38081https://curecurrent.com/trials/study-of-gdc-0941-or-gdc-0980-with-fulvestrant-versus-fulvestrant-in-advanced-or-metastatic-breast-cancer-in-participant-38082https://curecurrent.com/trials/a-non-interventional-study-of-the-occurrence-rate-of-non-small-cell-lung-cancer-colon-cancer-breast-cancer-gastric-cance-38083https://curecurrent.com/trials/primados-study-a-study-of-avastin-bevacizumab-plus-docetaxel-for-first-line-treatment-of-patients-with-metastatic-breast-38084https://curecurrent.com/trials/a-study-of-capecitabine-rapid-disintegrating-tablets-rdt-versus-commercial-xeloda-in-patients-with-solid-tumours-38085https://curecurrent.com/trials/trastuzumab-and-trastuzumab-mcc-dm1-administered-intravenously-and-gdc-0941-administered-orally-to-patients-with-her2-po-38086https://curecurrent.com/trials/effect-of-gdc-0810-on-the-pharmacokinetics-of-pravastatin-in-healthy-female-subjects-of-non-childbearing-potential-38087https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-combination-with-avastin-bevacizumab-and-sequential-xeloda-capecitabine-or-docetaxel-38088https://curecurrent.com/trials/study-of-the-safety-and-pharmacology-of-gdc-0980-in-combination-with-paclitaxel-with-or-without-bevacizumab-in-patients-38089https://curecurrent.com/trials/safety-of-herceptin-trastuzumab-in-metastatic-breast-cancer-38090https://curecurrent.com/trials/a-study-to-determine-the-safety-and-tolerability-of-herceptin-as-an-adjuvant-therapy-of-early-breast-cancer-38091https://curecurrent.com/trials/a-study-to-evaluate-the-biological-activity-of-r1507-in-women-with-operable-breast-cancer-38092https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-in-patients-with-her2-positive-metastatic-breast-cancer-and-normal-or-reduced-hepatic-f-38093https://curecurrent.com/trials/primary-chemotherapy-in-patients-with-her2-positive-early-breast-cancer-38094https://curecurrent.com/trials/an-open-label-multi-center-phase-trial-to-evaluate-the-efficacy-and-safety-of-sequential-neoadjuvant-chemotherapy-with-d-38095https://curecurrent.com/trials/the-safety-and-efficacy-of-jobelyn-in-the-treatment-of-breast-cancer-patients-38096https://curecurrent.com/trials/paclitaxel-followed-by-fec-versus-paclitaxel-and-rad001-followed-by-fec-in-women-with-breast-cancer-38097https://curecurrent.com/trials/study-of-nab-paclitaxel-abraxane-treatment-in-patients-with-metastatic-breast-cancer-in-routine-clinical-practice-38098https://curecurrent.com/trials/an-observational-study-in-patients-with-breast-cancer-and-bone-metastases-receiving-ibandronate-bondronat-38099https://curecurrent.com/trials/s1-plus-docetaxel-versus-capecitabine-plus-docetaxel-first-line-treatment-in-patients-with-advanced-breast-cancer-38100https://curecurrent.com/trials/identifying-subgroups-with-high-cardiovascular-risk-in-breast-cancer-survivors-38101https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-versus-capecitabine-lapatinib-in-participants-with-her2-positive-locally-advanced-or-me-38102https://curecurrent.com/trials/phase-ii-trial-with-metronomic-capecitabine-plus-oral-vinorelbine-for-metastatic-breast-cancer-38103https://curecurrent.com/trials/premenopausal-endocrine-responsive-chemotherapy-trial-38104https://curecurrent.com/trials/whole-body-magnetic-resonance-imaging-mri-for-detection-of-cancer-metastases-38105https://curecurrent.com/trials/a-couples-approach-to-enhance-breast-cancer-survivorship-38106https://curecurrent.com/trials/an-early-phase-clinical-trial-to-evaluate-the-feasibility-of-cest-mri-in-patients-with-early-stage-breast-cancer-38107https://curecurrent.com/trials/anti-1-amino-3-18f-fluorocyclobutyl-1-carboxylic-acid-anti-18f-facbc-positron-emission-tomography-pet-ct-of-the-breast-38108https://curecurrent.com/trials/pharmacist-s-influence-on-breast-cancer-patient-quality-of-life-38109https://curecurrent.com/trials/sentinel-lymph-node-biopsy-using-peritumoral-injection-with-blue-dye-confirmation-38110https://curecurrent.com/trials/pectoral-nerve-blockade-in-mastectomy-38111https://curecurrent.com/trials/impact-of-cox2-on-sera-biomarkers-from-obese-subjects-38112https://curecurrent.com/trials/integrative-approaches-for-cancer-survivorship-38113https://curecurrent.com/trials/effects-of-omega-3-fatty-acids-on-risk-factors-for-breast-cancer-in-pre-menopausal-women-38114https://curecurrent.com/trials/trastuzumab-in-combination-with-amg-479-in-her-2-overexpressing-mbc-progressing-on-trastuzumab-38115https://curecurrent.com/trials/age-related-changes-in-the-immune-system-and-their-impact-on-elderly-breast-cancer-38116https://curecurrent.com/trials/examining-the-relationships-between-sleep-fatigue-and-pain-in-aromatase-inhibitor-treated-patients-38117https://curecurrent.com/trials/preoperative-imaging-in-diep-flap-breast-reconstruction-38118https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-empegfilgrastim-for-neutropenia-prophylaxis-in-breast-cancer-patients-38119https://curecurrent.com/trials/is-any-additional-information-gained-regarding-margins-using-3d-tomosynthesis-vs-2d-conventional-digital-imaging-when-im-38120https://curecurrent.com/trials/evaluate-the-safety-profile-and-ability-of-tw1025-oral-solution-to-decrease-fatigue-38121https://curecurrent.com/trials/treatment-of-benign-breast-deformities-and-post-segmental-mastectomy-breast-deformities-with-autologous-fat-grafting-aft-38122https://curecurrent.com/trials/dose-escalation-followed-by-study-of-rad001-in-combination-with-trastuzumab-in-her2-positive-metastatic-breast-cancer-38123https://curecurrent.com/trials/forecyte-breast-aspirator-for-sample-collection-and-cytological-testing-of-nipple-aspirate-fluid-38124https://curecurrent.com/trials/efficacy-and-safety-of-dignicap-system-for-preventing-chemotherapy-induced-alopecia-38125https://curecurrent.com/trials/preoperative-trial-of-sorafenib-in-combination-with-cisplatin-followed-by-paclitaxel-for-early-stage-breast-cancer-38126https://curecurrent.com/trials/study-of-preoperative-chemotherapy-for-early-triple-negative-or-her2-positive-operable-breast-cancer-38127https://curecurrent.com/trials/leuplin-sr-11-25-mg-injection-kit-specified-drug-use-survey-qol-survey-in-premenopausal-breast-cancer-patients-38128https://curecurrent.com/trials/a-randomized-phase-2-neoadjuvant-study-of-weekly-paclitaxel-with-or-without-lcl161-in-patients-with-triple-negative-brea-38129https://curecurrent.com/trials/relational-and-emotional-mechanisms-of-a-supportive-expressive-group-intervention-in-breast-cancer-38130https://curecurrent.com/trials/safety-study-of-human-muc-1-mucin-1-adenoviral-vector-vaccine-for-immunotherapy-of-epithelial-cancers-38131https://curecurrent.com/trials/personalised-program-for-women-treated-for-hodgkin-disease-38132https://curecurrent.com/trials/microrna-of-human-epidermal-growth-factor-receptor-2-her2-positive-patient-treated-with-herceptin-38133https://curecurrent.com/trials/safety-and-efficacy-of-sentinel-node-biopsy-omission-for-breast-cancer-patients-who-plan-to-have-adjuvant-chemotherapy-38134https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-in-comparison-with-treatment-of-physician-s-choice-in-participants-with-her2-positive-b-38135https://curecurrent.com/trials/phase-ii-pilot-study-assessing-efficacy-of-a-cisplatin-m-tronomic-cyclophosphamide-treatment-in-patients-with-stade-iv-t-38136https://curecurrent.com/trials/molecular-breast-imaging-in-women-with-atypia-and-lcis-38137https://curecurrent.com/trials/phase-i-dose-study-to-look-at-the-safety-and-pharmacokinetics-of-azd8835-in-patients-with-advanced-solid-tumours-38138https://curecurrent.com/trials/lymphedema-upper-limb-of-breast-cancer-through-muscle-strengthening-associated-with-complex-physical-therapy-38139https://curecurrent.com/trials/eribulin-mesylate-phase-iv-clinical-trial-in-korean-patients-with-metastatic-or-locally-advanced-breast-cancer-38140https://curecurrent.com/trials/a-study-of-eribulin-mesylate-with-trastuzumab-for-advanced-or-recurrent-human-epidermal-growth-factor-receptor-2-positiv-38141https://curecurrent.com/trials/a-prospective-comparative-study-between-oncoplastic-breast-surgery-and-standard-wide-local-excision-38142https://curecurrent.com/trials/chemotherapy-plus-bone-marrow-or-peripheral-stem-cell-transplantation-in-treating-patients-with-recurrent-or-refractory-38143https://curecurrent.com/trials/vaccine-therapy-with-or-without-sirolimus-in-treating-patients-with-ny-eso-1-expressing-solid-tumors-38144https://curecurrent.com/trials/study-of-the-outcomes-of-intraoperative-margin-assessment-with-marginprobe-38145https://curecurrent.com/trials/trial-of-eribulin-followed-by-doxorubicin-cyclophosphamide-for-her2-negative-locally-advanced-breast-cancer-38146https://curecurrent.com/trials/bone-marrow-micrometastases-in-patients-with-early-stage-breast-cancer-38147https://curecurrent.com/trials/pre-pectoral-breast-reconstruction-part-1-38148https://curecurrent.com/trials/pre-pectoral-breast-reconstruction-part-2-38149https://curecurrent.com/trials/vortioxetine-for-mdd-cognition-and-systemic-inflammatory-biomarkers-38150https://curecurrent.com/trials/breast-cancer-biomarker-sample-collection-for-the-dtectdx-v2-assay-proof-of-concept-protocol-38151https://curecurrent.com/trials/my-lifestyle-intervention-of-food-and-exercise-38152https://curecurrent.com/trials/effectiveness-of-home-based-exercise-in-quality-of-life-and-physical-fitness-in-older-woman-in-breast-cancer-treatment-38153https://curecurrent.com/trials/e3-breast-cancer-taxotere-combination-38154https://curecurrent.com/trials/safety-study-of-pb-tcmc-trastuzumab-radio-immunotherapy-38155https://curecurrent.com/trials/assessment-of-breast-cancer-response-to-neoadjuvant-anthracycline-based-chemotherapy-by-fdg-pet-and-molecular-markers-38156https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-herceptin-trastuzumab-and-xeloda-capecitabine-in-patients-with-her2-p-38157https://curecurrent.com/trials/pet-ct-in-the-initial-staging-of-breast-cancer-and-in-the-early-assessment-of-response-to-neoadjuvant-chemotherapy-38158https://curecurrent.com/trials/a-phase-ii-study-evaluating-the-role-of-androgen-receptors-as-targets-for-therapy-of-pre-treated-post-menopausal-patient-38159https://curecurrent.com/trials/multipeptide-vaccine-for-advanced-breast-cancer-38160https://curecurrent.com/trials/epirubicin-and-cyclophosphamide-followed-by-docetaxel-and-trastuzumab-in-treating-women-with-her2-positive-stage-iii-or-38161https://curecurrent.com/trials/overcoming-obstacles-to-clinical-trials-enrollment-through-a-navigator-program-38162https://curecurrent.com/trials/an-observational-study-of-xeloda-capecitabine-in-participants-with-metastatic-or-advanced-breast-cancer-38163https://curecurrent.com/trials/a-study-evaluating-veliparib-as-a-single-agent-or-in-combination-with-chemotherapy-in-subjects-with-solid-tumors-38164https://curecurrent.com/trials/study-the-usefulness-of-bio-impedance-spectroscopy-in-the-early-assessment-of-breast-cancer-related-lymphoedema-38165https://curecurrent.com/trials/neoadjuvant-letrozole-in-treating-postmenopausal-women-with-estrogen-receptor-positive-and-or-progesterone-receptor-posi-38166https://curecurrent.com/trials/pilot-study-evaluating-the-oncogramme-analysis-of-response-to-induction-treatment-of-patients-with-breast-or-ovarian-can-38167https://curecurrent.com/trials/effect-of-pectoral-nerve-block-on-post-op-pain-in-patients-undergoing-mastectomy-and-immediate-reconstruction-38168https://curecurrent.com/trials/weekly-paclitaxel-carboplatin-bevacizumab-as-first-line-therapy-for-triple-negative-breast-cancer-38169https://curecurrent.com/trials/oocyte-recovery-during-tamoxifen-adjuvant-therapy-38170https://curecurrent.com/trials/effectiveness-of-a-psycho-educational-group-peg-intervention-on-supportive-care-and-survivorship-issues-in-early-stage-b-38171https://curecurrent.com/trials/a-phase-ii-study-of-rapamycin-and-trastuzumab-for-patients-with-her-2-receptor-positive-metastatic-breast-cancer-38172https://curecurrent.com/trials/low-dose-molecular-breast-imaging-comparison-of-breast-cancer-detection-rate-at-initial-screening-and-two-year-follow-up-38173https://curecurrent.com/trials/selective-lymph-node-dissection-using-fluorescent-dye-in-node-positive-breast-cancer-38174https://curecurrent.com/trials/impact-of-chemotherapy-followed-by-aromatase-inhibitors-on-bone-health-of-women-with-er-positive-early-breast-cancer-38175https://curecurrent.com/trials/the-efficacy-and-safety-of-peg-rhg-csf-in-neutropenia-after-chemotherapy-38176https://curecurrent.com/trials/doxorubicin-hydrochloride-liposome-injection-combination-with-cyclophosphamide-vs-pirarubicin-combination-with-cyclophos-38177https://curecurrent.com/trials/the-study-on-the-clinical-utility-of-liquid-biopsy-in-breast-cancer-38178https://curecurrent.com/trials/low-dose-oral-cyclophosphamide-and-methotrexate-maintenance-for-hormone-receptor-negative-early-breast-cancer-38179https://curecurrent.com/trials/pilot-study-of-sorafenib-and-bi-weekly-capecitabine-in-patients-with-advanced-breast-and-gastrointestinal-tumors-38180https://curecurrent.com/trials/an-innovation-during-the-surgical-wait-evaluation-of-the-opportunity-for-intervention-38181https://curecurrent.com/trials/the-impact-of-oncoplastic-breast-surgery-on-the-oncological-safety-and-patient-satisfaction-38182https://curecurrent.com/trials/evaluation-of-homeopathic-treatment-for-hot-flashes-in-non-metastatic-breast-cancer-38183https://curecurrent.com/trials/trial-of-neoadjuvant-trastuzumab-emtansine-in-patients-with-her2-equivocal-breast-cancer-38184https://curecurrent.com/trials/gamma-delta-tocotrienol-as-potential-maintenance-treatment-in-women-with-metastatic-breast-cancer-38185https://curecurrent.com/trials/study-of-trans-tissular-migration-of-macrophages-associated-to-human-breast-cancer-38186https://curecurrent.com/trials/cyberknife-after-breast-conservative-surgery-38187https://curecurrent.com/trials/aromatase-inhibitor-associated-musculoskeletal-symptoms-in-non-metastatic-post-menopausal-breast-cancer-patients-38188https://curecurrent.com/trials/a-translational-trial-on-molecular-markers-and-functional-imaging-to-predict-response-of-preoperative-treatment-of-breas-38189https://curecurrent.com/trials/a-study-of-mm-121-in-combination-with-paclitaxel-in-patients-with-advanced-gynecologic-and-breast-cancers-38190https://curecurrent.com/trials/a-safety-study-of-mm-121-with-cetuximab-and-irinotecan-in-patients-with-advanced-cancers-38191https://curecurrent.com/trials/drug-drug-interaction-study-using-rosuvastatin-as-a-breast-cancer-resistant-protein-efflux-transporter-organic-anion-tra-38192https://curecurrent.com/trials/the-breast-surgery-enlight-and-lightpath-imaging-system-study-38193https://curecurrent.com/trials/neoadjuvant-sunitinib-with-paclitaxel-carboplatin-in-patients-with-triple-negative-breast-cancer-38194https://curecurrent.com/trials/a-trial-of-doxorubicin-cyclophosphamide-ac-docetaxel-d-and-alternating-ac-and-d-for-metastatic-breast-cancer-38195https://curecurrent.com/trials/dose-dense-docetaxel-before-or-after-doxorubicin-cyclophosphamide-in-axillary-node-positive-breast-cancer-38196https://curecurrent.com/trials/a-study-of-combinations-of-d-cik-immunotherapy-and-anti-pd-1-in-refractory-solid-tumors-38197https://curecurrent.com/trials/preoperative-cisplatin-in-early-stage-breast-cancer-38198https://curecurrent.com/trials/capecitabine-and-bevacizumab-vinorelbine-in-metastatic-breast-cancer-38199https://curecurrent.com/trials/chemotherapy-for-elderly-patients-diagnosed-with-localized-her2-positive-breast-cancer-38200https://curecurrent.com/trials/prospective-and-retrospective-breast-cancer-database-38201https://curecurrent.com/trials/iressa-follow-up-trial-38202https://curecurrent.com/trials/this-study-is-to-assess-the-efficacy-and-safety-of-zd6474-in-subjects-with-metastatic-breast-cancer-38203https://curecurrent.com/trials/effect-aerobic-training-on-women-with-breast-cancer-after-chemotherapy-38204https://curecurrent.com/trials/a-novel-e-health-approach-in-optimizing-treatment-for-seniors-optimum-study-38205https://curecurrent.com/trials/a-biological-sample-collection-protocol-of-women-with-and-without-breast-cancer-38206https://curecurrent.com/trials/investigating-patient-satisfaction-with-oral-anti-cancer-treatment-in-patients-with-hormone-receptor-positive-her2-recep-38207https://curecurrent.com/trials/a-study-of-perjeta-pertuzumab-in-combination-with-herceptin-trastuzumab-in-participants-with-metastatic-breast-cancer-38208https://curecurrent.com/trials/breast-cancer-prevention-education-38209https://curecurrent.com/trials/effect-of-chemotherapy-and-radiation-prior-to-surgery-for-triple-negative-breast-cancer-38210https://curecurrent.com/trials/increasing-adherence-to-follow-up-of-breast-abnormalities-in-low-income-korean-american-women-38211https://curecurrent.com/trials/xebra-study-an-observational-study-of-xeloda-capecitabine-in-combination-with-docetaxel-in-first-line-in-participants-wi-38212https://curecurrent.com/trials/breast-cancer-screening-intervention-38213https://curecurrent.com/trials/indole-3-carbinol-in-preventing-breast-cancer-in-nonsmoking-women-who-are-at-high-risk-for-breast-cancer-38214https://curecurrent.com/trials/institut-paoli-calmettes-lymphoma-database-38215https://curecurrent.com/trials/institut-paoli-calmettes-breast-cancer-database-38216https://curecurrent.com/trials/genetic-counseling-in-african-american-women-38217https://curecurrent.com/trials/trastuzumab-administered-concurrently-or-sequentially-to-anthracycline-containing-adjuvant-regimen-for-breast-cancer-38218https://curecurrent.com/trials/phase-1b-2-study-of-bkm120-plus-trastuzumab-in-patients-with-her2-positive-breast-cancer-38219https://curecurrent.com/trials/roll-vs-wgll-for-non-palpable-breast-lesions-38220https://curecurrent.com/trials/developing-plasma-dna-as-a-surrogate-for-tumor-biopsy-to-identify-tumor-genetic-alterations-in-patients-with-advanced-br-38221https://curecurrent.com/trials/effect-of-a-goal-setting-intervention-on-exercise-in-women-with-metastatic-breast-cancer-an-exploration-of-the-lipogenic-38222https://curecurrent.com/trials/single-versus-multiple-injection-ultrasound-guided-paravertebral-blocks-38223https://curecurrent.com/trials/alisertib-in-adults-with-nonhematological-malignancies-followed-by-alisertib-in-lung-breast-head-and-neck-or-gastroesoph-38224https://curecurrent.com/trials/local-surgery-for-metastatic-breast-cancer-38225https://curecurrent.com/trials/comparison-of-combination-chemotherapy-regimens-in-treating-older-women-who-have-undergone-surgery-for-breast-cancer-38226https://curecurrent.com/trials/pecs-ii-block-and-pab-could-be-an-alternative-in-breast-surgery-38227https://curecurrent.com/trials/the-efficacy-and-safety-of-endostar-combined-with-taxane-based-regimens-for-her-2-negative-mbc-patients-38228https://curecurrent.com/trials/a-study-to-assess-the-effects-of-mk0822-in-reducing-the-risk-of-bone-metastasis-in-women-with-breast-cancer-0822-029-38229https://curecurrent.com/trials/pilocarpine-in-treating-vaginal-dryness-in-patients-with-breast-cancer-38230https://curecurrent.com/trials/reader-study-for-image-quality-of-cone-beam-breast-ct-system-38231https://curecurrent.com/trials/from-the-characterization-of-the-cholesterol-epoxide-pathway-deregulation-to-new-therapeutic-perspectives-in-breast-canc-38232https://curecurrent.com/trials/accelerated-partial-breast-irradiation-using-intensity-modulated-radiotherapy-versus-whole-breast-irradiation-38233https://curecurrent.com/trials/lightpathtm-imaging-system-for-ex-vivo-assessment-of-margin-and-lymph-node-status-in-breast-cancer-surgical-specimens-38234https://curecurrent.com/trials/study-of-d-methadone-in-patients-with-chronic-pain-38235https://curecurrent.com/trials/breast-cancer-chemotherapy-risk-prediction-mathematical-model-38236https://curecurrent.com/trials/whole-body-mri-for-the-detection-of-metastasis-38237https://curecurrent.com/trials/the-clinical-significance-of-cellular-immune-adjuvant-therapy-of-triple-negative-breast-cancer-38238https://curecurrent.com/trials/a-multicenter-study-of-clinical-epidemiology-of-breast-cancer-in-shaanxi-province-of-china-38239https://curecurrent.com/trials/a-pilot-surveillance-study-to-monitor-natural-killer-cells-and-circulating-tumor-cells-in-women-with-previously-treated-38240https://curecurrent.com/trials/clinical-trial-of-postmastectomy-radiotherapy-in-breast-cancer-with-one-to-three-positive-nodes-38241https://curecurrent.com/trials/impact-of-chemotherapy-on-ovarian-reserve-in-young-women-with-breast-cancer-38242https://curecurrent.com/trials/physical-activity-to-reduce-joint-pain-during-aromatase-inhibitor-therapy-38243https://curecurrent.com/trials/attitudes-about-childbearing-and-fertility-with-inherited-breast-and-ovarian-cancer-syndromes-hboc-38244https://curecurrent.com/trials/the-telemark-score-a-reliable-method-for-evaluation-of-results-after-breast-surgery-38245https://curecurrent.com/trials/effectiveness-of-acupuncture-in-post-mastectomy-patients-with-tissue-expanders-38246https://curecurrent.com/trials/t-cell-receptor-transduced-t-cells-targeting-ny-eso-1-for-treatment-of-patients-with-ny-eso-1-expressing-malignancies-38247https://curecurrent.com/trials/ultra-high-field-mri-and-mrs-techniques-in-diagnosing-breast-cancer-38248https://curecurrent.com/trials/azd2171-in-addition-to-fulvestrant-in-patients-with-advanced-breast-cancer-38249https://curecurrent.com/trials/4r-for-guideline-indicated-brca-testing-of-breast-center-patients-38250https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-plus-herceptin-trastuzumab-in-patients-with-primary-inflammatory-her2-positive-breast-can-38251https://curecurrent.com/trials/breast-mri-for-newly-diagnosed-breast-cancer-impact-on-re-excision-lumpectomy-38252https://curecurrent.com/trials/delayed-adjuvant-herceptin-treatment-in-patients-with-her-2-positive-breast-cancer-38253https://curecurrent.com/trials/mometasone-furoate-in-preventing-radiation-dermatitis-in-patients-undergoing-radiation-therapy-to-the-breast-or-chest-wa-38254https://curecurrent.com/trials/pregabalin-in-treating-women-with-hot-flashes-38255https://curecurrent.com/trials/study-to-test-the-value-of-a-pain-modulation-test-in-predicting-persistent-postoperative-pain-after-breast-cancer-surger-38256https://curecurrent.com/trials/study-of-survivorship-care-plans-and-outcomes-in-underserved-breast-cancer-survivors-38257https://curecurrent.com/trials/effects-of-a-group-residential-retreat-on-cancer-outcomes-38258https://curecurrent.com/trials/tissue-procurement-protocol-for-patients-undergoing-neoadjuvant-systemic-therapy-for-breast-cancer-38259https://curecurrent.com/trials/the-use-of-botulinum-toxin-a-in-two-stage-tissue-expander-implant-breast-reconstruction-38260https://curecurrent.com/trials/luteal-vs-follicular-surgical-oophorectomy-and-tamoxifen-in-premenopausal-women-with-metastatic-hormone-receptor-positiv-38261https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-capecitabine-prior-to-surgery-in-women-with-breast-cancer-38262https://curecurrent.com/trials/effect-of-chemotherapy-on-pain-sensitivity-and-patient-reported-symptoms-38263https://curecurrent.com/trials/initial-assessment-of-an-internet-based-symptom-management-intervention-in-early-stage-breast-cancer-38264https://curecurrent.com/trials/talazoparib-and-hsp90-inhibitor-at13387-in-treating-patients-with-metastatic-advanced-solid-tumor-or-recurrent-ovarian-f-38265https://curecurrent.com/trials/a-pharmacogenomics-study-for-breast-cancer-patients-undergoing-adjuvant-chemotherapy-with-doxorubicin-a-cyclophosphamide-38266https://curecurrent.com/trials/brain-function-in-premenopausal-women-receiving-tamoxifen-with-or-without-ovarian-function-suppression-for-early-stage-b-38267https://curecurrent.com/trials/phib-bkm120-or-bez235-endocrine-treatment-in-post-menopausal-patients-with-hormone-receptor-metastatic-breast-cancer-38268https://curecurrent.com/trials/standard-chemotherapy-followed-by-capecitabine-as-prolonged-postoperative-adjuvant-treatment-for-breast-cancer-38269https://curecurrent.com/trials/choices-for-latinas-and-clinical-trials-38270https://curecurrent.com/trials/a-study-of-lifestyle-intervention-in-overweight-or-obese-women-with-early-stage-breast-cancer-38271https://curecurrent.com/trials/breast-cancer-risk-biomarkers-in-premenopausal-women-38272https://curecurrent.com/trials/experience-of-the-patient-treated-with-trastuzumab-herceptin-as-adjuvant-for-breast-cancer-38273https://curecurrent.com/trials/da-versus-dac-as-postoperative-adjuvant-treatment-for-early-stage-breast-cancer-38274https://curecurrent.com/trials/molecular-signature-of-valproic-acid-in-breast-cancer-with-functional-imaging-assessment-a-pilot-38275https://curecurrent.com/trials/study-on-efficacy-and-safety-of-cblb612-for-neutropenia-prophylaxis-38276https://curecurrent.com/trials/serratus-plane-block-for-the-prevention-of-chronic-pain-after-breast-cancer-surgery-38277https://curecurrent.com/trials/oncotype-dx-in-estrogen-receptor-positive-er-her-2-negative-her-2-1-3-node-positive-pn1-breast-cancer-38278https://curecurrent.com/trials/radioactive-iodide-131i-treatment-of-124i-pet-ct-detected-breast-cancers-38279https://curecurrent.com/trials/x-versus-placebo-as-postoperative-adjuvant-treatment-for-elder-breast-cancer-38280https://curecurrent.com/trials/nutrition-physical-activity-and-cognition-in-breast-cancer-survivors-38281https://curecurrent.com/trials/afatinib-bibw2992-in-her2-human-epidermal-growth-factor-receptor-2-overexpressing-inflammatory-breast-cancer-38282https://curecurrent.com/trials/safety-and-efficiency-of-t-cell-against-breast-cancer-her-er-and-pr-38283https://curecurrent.com/trials/zoledronate-calcium-and-vitamin-d-in-preventing-bone-loss-in-women-receiving-adjuvant-chemotherapy-for-breast-cancer-38284https://curecurrent.com/trials/interleukin-12-in-treating-patients-with-metastatic-or-recurrent-breast-cancer-38285https://curecurrent.com/trials/acellular-dermal-matrix-in-breast-reconstruction-38286https://curecurrent.com/trials/trial-of-combined-aerobic-and-resistance-exercise-in-breast-cancer-survivors-38287https://curecurrent.com/trials/modulation-of-breast-cancer-risk-biomarkers-by-high-dose-vitamin-d-38288https://curecurrent.com/trials/study-of-panobinostat-monotherapy-in-women-with-her2-negative-locally-recurrent-or-metastatic-breast-cancer-38289https://curecurrent.com/trials/delayed-immediate-breast-reconstruction-38290https://curecurrent.com/trials/a-study-of-alt-836-in-combination-with-gemcitabine-for-locally-advanced-or-metastatic-solid-tumors-38291https://curecurrent.com/trials/delayed-delayed-breast-reconstruction-38292https://curecurrent.com/trials/irinotecan-in-treating-patients-with-refractory-metastatic-breast-cancer-38293https://curecurrent.com/trials/docetaxel-in-treating-patients-with-solid-tumors-38294https://curecurrent.com/trials/gabapentin-with-or-without-antidepressants-in-treating-hot-flashes-in-women-who-have-had-breast-cancer-or-have-concerns-38295https://curecurrent.com/trials/therapy-for-locally-advanced-breast-cancer-using-doxil-paclitaxel-and-cyclophosphamide-with-avastin-38296https://curecurrent.com/trials/phase-i-open-label-dose-escalation-study-to-investigate-the-safety-pharmacokinetics-of-azd5312-in-patients-with-androgen-38297https://curecurrent.com/trials/grn1005-alone-or-in-combination-with-trastuzumab-in-breast-cancer-patients-with-brain-metastases-38298https://curecurrent.com/trials/prognostic-study-of-sentinel-lymph-node-and-bone-marrow-metastases-in-women-with-stage-i-or-stage-iia-breast-cancer-38299https://curecurrent.com/trials/gemcitabine-and-cisplatin-in-treating-patients-with-metastatic-breast-cancer-38300https://curecurrent.com/trials/black-cohosh-in-treating-hot-flashes-in-women-who-have-or-who-are-at-risk-of-developing-breast-cancer-38301https://curecurrent.com/trials/biomarkers-in-native-american-women-with-breast-cancer-38302https://curecurrent.com/trials/standard-therapy-with-or-without-dalteparin-in-treating-patients-with-advanced-breast-lung-colorectal-or-prostate-cancer-38303https://curecurrent.com/trials/epoetin-alfa-in-treating-anemia-in-patients-who-are-receiving-chemotherapy-38304https://curecurrent.com/trials/effect-of-the-livestrong-at-the-ymca-exercise-program-on-cancer-related-outcomes-in-cancer-survivors-38305https://curecurrent.com/trials/risedronate-in-preventing-bone-loss-in-premenopausal-women-receiving-chemotherapy-for-primary-breast-cancer-38306https://curecurrent.com/trials/changes-in-breast-density-and-blood-hormone-levels-in-postmenopausal-women-receiving-anastrozole-or-exemestane-for-breas-38307https://curecurrent.com/trials/shark-cartilage-in-treating-patients-with-advanced-colorectal-or-breast-cancer-38308https://curecurrent.com/trials/soy-protein-supplement-in-treating-hot-flashes-in-postmenopausal-women-receiving-tamoxifen-for-breast-disease-38309https://curecurrent.com/trials/lung-inflammation-and-lung-metastases-from-breast-cancer-38310https://curecurrent.com/trials/docetaxel-and-st-john-s-wort-in-treating-patients-with-solid-tumors-that-cannot-be-removed-by-surgery-38311https://curecurrent.com/trials/hormone-therapy-or-chemotherapy-before-surgery-based-on-gene-expression-analysis-in-treating-patients-with-breast-cancer-38312https://curecurrent.com/trials/low-dose-bevacizumab-and-pemetrexed-versus-tpc-in-metastatic-her2-negative-breast-cancer-patients-38313https://curecurrent.com/trials/dynamic-infrared-thermography-in-breast-cancer-diagnostics-38314https://curecurrent.com/trials/correlation-of-menstrual-cycle-phase-at-time-of-primary-surgery-with-5-year-disease-free-survival-in-women-with-stage-i-38315https://curecurrent.com/trials/trastuzumab-with-or-without-tamoxifen-in-treating-women-with-progressive-stage-iv-breast-cancer-38316https://curecurrent.com/trials/trial-evaluating-dovitinib-combined-with-fulvestrant-in-postmenopausal-patients-with-her2-and-hr-breast-cancer-38317https://curecurrent.com/trials/positron-emission-mammography-with-fluorothymidine-flt-to-evaluate-treatment-response-to-chemotherapy-in-breast-cancer-38318https://curecurrent.com/trials/improving-fatigue-a-pilot-study-of-acupuncture-and-patient-education-for-breast-cancer-survivors-38319https://curecurrent.com/trials/phase-i-ii-study-of-neoadjuvant-lapatinib-in-breast-cancer-38320https://curecurrent.com/trials/ici-182780-in-treating-women-with-metastatic-breast-cancer-38321https://curecurrent.com/trials/egb761-in-maintaining-mental-clarity-in-women-receiving-chemotherapy-for-newly-diagnosed-breast-cancer-38322https://curecurrent.com/trials/docetaxel-carboplatin-and-pegfilgrastim-in-treating-patients-who-are-undergoing-surgery-for-stage-ii-or-stage-iii-breast-38323https://curecurrent.com/trials/vinorelbine-in-treating-older-women-with-stage-iv-breast-cancer-38324https://curecurrent.com/trials/acute-pain-trajectories-and-persistent-pain-after-breast-cancer-surgery-38325https://curecurrent.com/trials/yoga-for-aromatase-inhibitor-associated-joint-pain-38326https://curecurrent.com/trials/biomarkers-in-tissue-samples-from-older-women-with-breast-cancer-38327https://curecurrent.com/trials/observational-study-of-diffuse-large-b-cell-primary-breast-lymphomas-treated-with-rchop-xrt-38328https://curecurrent.com/trials/weight-management-among-breast-cancer-survivors-38329https://curecurrent.com/trials/peci-spb-vs-intercostal-nerve-block-for-the-management-of-postoperative-pain-in-latissimus-dorsi-flap-reconstruction-38330https://curecurrent.com/trials/a-prospective-clinical-study-for-evaluation-of-safe-resection-margin-in-breast-conserving-surgery-in-breast-cancer-38331https://curecurrent.com/trials/nausea-or-vomiting-in-patients-who-are-receiving-chemotherapy-for-breast-cancer-or-lung-cancer-38332https://curecurrent.com/trials/loss-of-grip-strength-bmi-and-adjuvant-endocrine-therapy-breast-cancer-38333https://curecurrent.com/trials/exercise-intervention-in-women-with-metastatic-breast-cancer-38334https://curecurrent.com/trials/effects-of-exercise-intervention-on-insulin-levels-in-breast-cancer-survivors-38335https://curecurrent.com/trials/a-cost-effective-handheld-breast-scanner-for-use-in-low-resource-environments-a-validation-study-38336https://curecurrent.com/trials/a-study-of-cdx-1401-in-patients-with-malignancies-known-to-express-ny-eso-1-38337https://curecurrent.com/trials/adolescent-daughters-response-and-adjustment-to-maternal-breast-cancer-38338https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-paclitaxel-and-pertuzumab-in-patients-with-her2-positive-locally-advanced-or-metastatic-38339https://curecurrent.com/trials/retrospective-analysis-of-effectiveness-and-safety-profile-of-anastrozole-and-letrozole-in-hr-breast-cancer-patients-38340https://curecurrent.com/trials/evaluation-of-the-cook-biodesign-nipple-reconstruction-cylinder-nrc-38341https://curecurrent.com/trials/breast-cancer-trials-education-program-38342https://curecurrent.com/trials/docetaxel-with-or-without-low-dose-short-course-sunitinib-in-refractory-solid-tumors-38343https://curecurrent.com/trials/randomized-study-of-doxorubicin-and-cyclophosphamide-with-or-without-intermittent-sunitinib-in-the-first-line-treatment-38344https://curecurrent.com/trials/a-study-of-delivering-a-mindfulness-app-intervention-to-accompany-supportive-care-among-women-with-breast-cancer-38345https://curecurrent.com/trials/big-data-and-text-mining-technologies-applied-for-breast-cancer-medical-data-analysis-38346https://curecurrent.com/trials/prospective-study-of-udp-gluconoryltransferase-2b17-genotype-as-a-predictive-marker-of-exemestane-pk-and-pd-38347https://curecurrent.com/trials/nk-cell-infusions-with-trastuzumab-for-patients-with-her2-breast-and-gastric-cancer-38348https://curecurrent.com/trials/improving-the-immune-system-with-human-il-7-vaccine-in-older-subjects-who-have-had-chemotherapy-38349https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-combination-with-2nd-line-chemotherapy-in-patients-with-her2-positive-metastatic-bre-38350https://curecurrent.com/trials/magnesium-oxide-in-treating-hot-flashes-in-menopausal-women-with-cancer-38351https://curecurrent.com/trials/dynamic-infrared-thermography-as-an-alternative-to-ct-angiography-38352https://curecurrent.com/trials/peg-rhg-csf-in-patients-with-breast-cancer-receiving-chemotherapy-38353https://curecurrent.com/trials/peg-rhg-csf-in-patients-with-breast-cancer-receiving-chemotherapy-to-prevent-neutropenia-38354https://curecurrent.com/trials/trial-of-2nd-generation-anti-cea-designer-t-cells-in-metastatic-breast-cancer-38355https://curecurrent.com/trials/combined-training-on-body-composition-of-postmenopausal-women-undergoing-treatment-for-breast-cancer-38356https://curecurrent.com/trials/evaluation-of-the-high-resolution-contrast-enhanced-low-dose-breast-ct-38357https://curecurrent.com/trials/studying-tailored-exercise-prescriptions-in-breast-cancer-patients-38358https://curecurrent.com/trials/safety-and-efficacy-study-of-eribulin-in-combination-with-bevacizumab-for-second-line-treatment-her2-mbc-patients-38359https://curecurrent.com/trials/orally-administrated-jbm-tc4-prevents-acute-radiodermatitis-in-breast-cancer-patients-38360https://curecurrent.com/trials/patient-navigation-in-the-safety-net-connectedd-38361https://curecurrent.com/trials/protocol-for-women-at-increased-risk-of-developing-breast-cancer-38362https://curecurrent.com/trials/mr-characterisation-localisation-of-breast-cancer-38363https://curecurrent.com/trials/fulvestrant-and-everolimus-plus-exemestane-in-metastatic-breast-cancer-38364https://curecurrent.com/trials/overcoming-endocrine-resistance-in-metastatic-breast-cancer-38365https://curecurrent.com/trials/fulvestrant-as-maintenance-therapy-after-first-line-chemotherapy-in-her2-postmenopausal-mbc-patients-38366https://curecurrent.com/trials/observation-of-medical-treatments-in-mbc-her2-negative-patients-38367https://curecurrent.com/trials/safety-and-qol-of-trastuzumab-with-lapatinib-or-chemiotherapy-in-mbc-and-her2-patients-refractory-to-anti-her2-therapies-38368https://curecurrent.com/trials/brazilian-randomized-study-impact-of-mri-for-breast-cancer-38369https://curecurrent.com/trials/clinical-application-of-ctdna-in-operable-breast-cancer-patients-38370https://curecurrent.com/trials/impact-of-chemotherapy-induced-alopecia-on-the-quality-of-life-of-women-with-breast-cancer-38371https://curecurrent.com/trials/temsirolimus-and-vinorelbine-ditartrate-in-treating-patients-with-unresectable-or-metastatic-solid-tumors-38372https://curecurrent.com/trials/randomized-phase-ii-trial-of-letrozole-with-or-without-dasatinib-as-first-and-second-line-treatment-for-hormone-receptor-38373https://curecurrent.com/trials/cancer-prevention-in-women-with-a-brca-mutation-38374https://curecurrent.com/trials/randomized-phase-ii-study-to-assess-pd-0332991-in-breast-cancer-38375https://curecurrent.com/trials/the-heartspare-study-stage-i-38376https://curecurrent.com/trials/tracking-feedback-registry-to-reduce-breast-cancer-treatment-disparities-38377https://curecurrent.com/trials/physical-and-emotional-benefits-of-group-dance-intervention-for-breast-cancer-survivors-38378https://curecurrent.com/trials/can-exercise-improve-cancer-associated-cognitive-dysfunction-38379https://curecurrent.com/trials/expanded-access-to-ang1005-for-individual-patients-38380https://curecurrent.com/trials/a-study-of-ac-followed-by-a-combination-of-paclitaxel-plus-trastuzumab-or-lapatinib-or-both-given-before-surgery-to-pati-38381https://curecurrent.com/trials/dose-dense-doxorubicin-cyclophosphamide-with-intermittent-low-dose-sunitinib-in-breast-cancer-patients-38382https://curecurrent.com/trials/imaging-with-111-indium-111in-pertuzumab-pmab-to-predict-response-to-trastuzumab-tmab-in-human-epidermal-growth-factor-2-38383https://curecurrent.com/trials/acupuncture-and-breast-cancer-rehabilitation-38384https://curecurrent.com/trials/flaxseed-in-preventing-breast-cancer-in-premenopausal-women-at-risk-of-developing-breast-cancer-38385https://curecurrent.com/trials/lenalidomide-in-combination-with-bevacizumab-sorafenib-temsirolimus-or-5-fluorouracil-leucovorin-oxaliplatin-folfox-38386https://curecurrent.com/trials/study-of-xl147-sar245408-in-combination-with-trastuzumab-or-paclitaxel-and-trastuzumab-in-subjects-with-metastatic-breas-38387https://curecurrent.com/trials/eribulin-halaven-use-for-the-treatment-of-advanced-breast-cancer-38388https://curecurrent.com/trials/effect-of-iranian-traditional-medicine-remedy-on-chemotherapy-induced-nausea-and-vomiting-38389https://curecurrent.com/trials/study-of-xl147-sar245408-or-xl765-sar245409-in-combination-with-letrozole-in-subjects-with-breast-cancer-38390https://curecurrent.com/trials/retrospective-study-assessment-treatment-response-faslodex-500-mg-38391https://curecurrent.com/trials/conventional-versus-hypofractionated-radiotherapy-in-node-positive-breast-cancer-38392https://curecurrent.com/trials/epigenetic-testing-for-breast-cancer-risk-stratification-38393https://curecurrent.com/trials/a-pilot-preoperative-trial-of-ganetespib-with-paclitaxel-for-triple-negative-breast-cancer-38394https://curecurrent.com/trials/a-study-of-bevacizumab-in-combination-with-gemcitabine-and-carboplatin-in-participants-with-triple-negative-metastatic-b-38395https://curecurrent.com/trials/docetaxel-plus-imatinib-mesylate-in-metastatic-breast-cancer-38396https://curecurrent.com/trials/insomnia-interventions-in-cancer-survivors-38397https://curecurrent.com/trials/randomized-trial-of-fulvestrant-with-or-without-dasatinib-in-men-and-postmenopausal-women-who-have-hormone-receptor-posi-38398https://curecurrent.com/trials/prognostic-evaluation-of-changing-endocrine-therapy-in-women-with-breast-cancer-38399https://curecurrent.com/trials/rucaparib-co-338-formally-called-ag-014699-or-pf-0136738-in-treating-patients-with-locally-advanced-or-metastatic-breast-38400https://curecurrent.com/trials/risk-assessment-tool-in-saudi-arabia-38401https://curecurrent.com/trials/outpatient-clinic-for-late-outcome-for-breast-carcinoma-in-maastro-clinic-38402https://curecurrent.com/trials/limiting-chemotherapy-side-effects-by-using-moxa-38403https://curecurrent.com/trials/neoadjuvant-chemotherapy-for-operable-premenopausal-breast-cancer-patients-38404https://curecurrent.com/trials/supr-study-supine-versus-prone-treatment-position-in-breast-radiotherapy-38405https://curecurrent.com/trials/enhancing-connections-helping-the-mother-with-breast-cancer-support-her-child-38406https://curecurrent.com/trials/histology-of-functional-density-in-premenopausal-breast-38407https://curecurrent.com/trials/trial-with-autologous-dendritic-cell-vaccination-in-patients-with-stage-ii-iii-her2-negative-breast-cancer-38408https://curecurrent.com/trials/combination-study-of-a-new-taxane-and-capecitabine-in-patients-with-metastatic-breast-cancer-38409https://curecurrent.com/trials/exemestane-and-celecoxib-in-postmenopausal-women-at-high-risk-for-breast-cancer-38410https://curecurrent.com/trials/outcome-of-pregnancy-and-breast-cancer-38411https://curecurrent.com/trials/electronic-xoft-intersociety-brachytherapy-trial-electronic-brachytherapy-ebt-for-treatment-of-early-stage-breast-cancer-38412https://curecurrent.com/trials/early-predictor-of-herceptin-cardio-toxicity-in-breast-cancer-patients-38413https://curecurrent.com/trials/the-effect-of-zhen-qi-shen-capsule-combined-with-yu-yi-kang-on-breast-cancer-and-lung-cancer-patients-with-chemotherapy-38414https://curecurrent.com/trials/the-effect-of-aromatase-inhibitors-on-cardiovascular-risk-factors-in-women-with-breast-cancer-38415https://curecurrent.com/trials/breast-cancer-in-young-women-is-it-different-38416https://curecurrent.com/trials/apbi-versus-ebrt-therapy-after-breast-conserving-surgery-for-low-risk-breast-cancer-38417https://curecurrent.com/trials/trial-of-exemestane-mm-121-in-postmenopausal-women-with-locally-advanced-or-metastatic-estrogen-receptor-positive-and-or-38418https://curecurrent.com/trials/letrozole-in-combination-with-lapatinib-in-neoadjuvant-treatment-of-early-breast-cancer-38419https://curecurrent.com/trials/evaluation-of-a-self-care-toolkit-in-surgical-breast-cancer-patients-38420https://curecurrent.com/trials/assessment-of-ability-of-breath-hold-for-left-sided-breast-cancer-radiation-therapy-to-reduce-side-effects-to-heart-38421https://curecurrent.com/trials/primary-systemic-therapy-in-operable-locally-advanced-breast-cancer-38422https://curecurrent.com/trials/the-jewels-in-our-genes-study-an-african-american-family-study-of-breast-cancer-38423https://curecurrent.com/trials/a-comparison-of-dermal-autograft-to-alloderm-in-breast-reconstruction-38424https://curecurrent.com/trials/erlotinib-and-everolimus-in-treating-patients-with-metastatic-breast-cancer-38425https://curecurrent.com/trials/newer-breast-mri-sequences-for-the-evaluation-of-breast-cancer-fiesta-vibrant-de-and-ideal-feasibility-evaluation-38426https://curecurrent.com/trials/treatment-of-depressive-symptoms-in-breast-cancer-patients-comparison-of-cognitive-therapy-and-bright-light-therapy-38427https://curecurrent.com/trials/faslodex-specific-clinical-experience-investigation-38428https://curecurrent.com/trials/goserelin-acetate-study-for-ovarian-function-in-patients-with-primary-breast-cancer-38429https://curecurrent.com/trials/integrated-positron-emission-tomography-magnetic-resonance-pet-mr-of-breast-cancer-38430https://curecurrent.com/trials/a-trial-of-panobinostat-and-trastuzumab-for-adult-female-patients-with-her2-positive-metastatic-breast-cancer-mbc-whose-38431https://curecurrent.com/trials/efficacy-and-safety-of-wuling-san-on-breast-cancer-related-lymphedema-38432https://curecurrent.com/trials/accelerated-radiotherapy-outcomes-in-women-38433https://curecurrent.com/trials/percist-criteria-for-response-evaluation-with-solid-tumors-38434https://curecurrent.com/trials/two-dimensional-2d-silicon-transducer-compression-plates-for-breast-ultrasound-38435https://curecurrent.com/trials/improving-cancer-pain-management-through-self-care-38436https://curecurrent.com/trials/three-dimensional-3d-ultrasound-in-predicting-response-to-breast-cancer-therapies-38437https://curecurrent.com/trials/study-of-larotaxel-in-combination-with-weekly-herceptin-in-patients-with-her2-positive-metastatic-breast-cancer-38438https://curecurrent.com/trials/cognition-in-breast-cancer-patients-the-impact-of-cancer-related-stress-38439https://curecurrent.com/trials/chemotherapy-induced-peripheral-neuropathy-survey-38440https://curecurrent.com/trials/a-trial-of-preoperative-mm-121-with-paclitaxel-in-her2-negative-breast-cancer-38441https://curecurrent.com/trials/comparing-radiaplexrx-hydrogel-and-standard-of-care-for-radiation-dermatitis-in-breast-cancer-patients-38442https://curecurrent.com/trials/characterization-of-breast-masses-incidentally-detected-on-chest-ct-38443https://curecurrent.com/trials/a-randomized-controlled-mindfulness-based-stress-reduction-intervention-in-women-with-breast-cancer-38444https://curecurrent.com/trials/an-observational-study-of-xeloda-capecitabine-in-patients-with-metastatic-colorectal-cancer-colon-cancer-in-the-adjuvant-38445https://curecurrent.com/trials/tenovus-cancer-choirs-study-the-benefits-of-singing-for-those-affected-by-cancer-38446https://curecurrent.com/trials/biomarker-research-study-for-pf-03084014-in-chemoresistant-triple-negative-breast-cancer-38447https://curecurrent.com/trials/an-observational-time-and-motion-study-of-trastuzumab-subcutaneous-sc-and-intravenous-iv-formulations-in-human-epidermal-38448https://curecurrent.com/trials/nir-hypoxia-imaging-of-breast-tumor-response-to-neoadjuvant-chemotherapy-in-vivo-38449https://curecurrent.com/trials/prospective-observational-study-in-patients-with-metastatic-breast-cancer-treated-with-anthracyclines-38450https://curecurrent.com/trials/paravertebral-block-pvb-combined-pectoral-musculature-blocks-for-modified-radical-mastectomy-mrm-38451https://curecurrent.com/trials/dual-integrin-v-3-and-grpr-targeting-pet-imaging-in-breast-cancer-patients-38452https://curecurrent.com/trials/paclitaxel-and-bavituximab-in-treating-patients-with-her2-negative-metastatic-breast-cancer-38453https://curecurrent.com/trials/the-change-cycle-intervention-for-improving-quality-of-life-in-breast-cancer-survivors-38454https://curecurrent.com/trials/human-breast-tissue-bioavailability-of-topically-applied-limonene-38455https://curecurrent.com/trials/pilot-study-of-cyclobenzaprine-for-treatment-of-sleep-disturbance-in-aromatase-inhibitor-treated-breast-cancer-patients-38456https://curecurrent.com/trials/screening-mri-for-cancer-recurrence-in-patients-treated-with-breast-conserving-therapy-38457https://curecurrent.com/trials/combined-elastography-and-color-doppler-ultrasonography-for-breast-screening-with-ultrasound-38458https://curecurrent.com/trials/overall-survival-and-disease-free-survival-in-breast-cancer-patients-under-cos-38459https://curecurrent.com/trials/efficacy-of-ketamine-added-to-local-anesthetic-in-modified-pectoral-block-for-management-of-postoperative-pain-38460https://curecurrent.com/trials/study-of-sentinel-lymph-node-assessment-following-previous-surgical-biopsy-for-early-breast-cancer-38461https://curecurrent.com/trials/comparison-trial-of-letrozole-to-anastrozole-in-the-adjuvant-treatment-of-postmenopausal-women-with-hormone-receptor-and-38462https://curecurrent.com/trials/effects-of-a-supervised-progressive-resistance-training-with-breast-cancer-patients-during-adjuvant-radiotherapy-38463https://curecurrent.com/trials/extended-endocrine-therapy-for-premenopausal-women-with-breast-cancer-38464https://curecurrent.com/trials/eribulin-use-for-the-treatment-of-advanced-breast-cancer-a-prospective-observational-registry-38465https://curecurrent.com/trials/women-s-health-initiative-whi-38466https://curecurrent.com/trials/pilot-functional-imaging-study-to-evaluate-mechanisms-underlying-chronic-pain-in-breast-cancer-patients-38467https://curecurrent.com/trials/neoadjuvant-doxorubicin-cyclophosphamide-followed-by-eribulin-chemotherapy-ace-in-operable-her2-negative-breast-cancer-38468https://curecurrent.com/trials/trial-of-afatinib-with-paclitaxel-for-neoadjuvant-therapy-of-tnbc-and-research-of-biomarkers-of-afatinib-38469https://curecurrent.com/trials/ph-1-adi-peg-20-plus-doxorubicin-patients-with-her2-negative-metastatic-breast-cancer-38470https://curecurrent.com/trials/risk-education-and-assessment-for-cancer-heredity-38471https://curecurrent.com/trials/psycho-esthetic-impact-of-tattoo-technology-as-part-of-mammary-reconstruction-after-surgery-against-breast-cancer-38472https://curecurrent.com/trials/effect-of-soy-supplementation-on-cellular-markers-in-normal-and-cancerous-breast-tissue-a-randomized-placebo-controlled-38473https://curecurrent.com/trials/optical-detection-of-malignancy-during-percutaneous-interventions-38474https://curecurrent.com/trials/prevention-of-post-mastectomy-breast-pain-using-ambulatory-continuous-paravertebral-blocks-38475https://curecurrent.com/trials/a-multicenter-breast-cancer-biospecimen-registry-38476https://curecurrent.com/trials/eap-expanded-access-protocol-of-lapatinib-combined-with-capecitabine-in-metastatic-breast-cancer-38477https://curecurrent.com/trials/persistent-pain-after-breast-cancer-treatment-ppbct-risk-factors-and-pathophysiological-mechanisms-38478https://curecurrent.com/trials/the-preemptive-analgesic-efficacy-of-nefopam-38479https://curecurrent.com/trials/positron-emission-mammography-pem-biopsy-accessory-for-the-diagnosis-of-breast-cancer-38480https://curecurrent.com/trials/neurotoxicity-characterization-study-of-nab-paclitaxel-versus-conventional-paclitaxel-in-metastatic-breast-cancer-38481https://curecurrent.com/trials/a-multicenter-randomized-clinical-trail-evaluate-effectiveness-and-security-of-capecitabine-or-endocrinotherapy-as-a-mai-38482https://curecurrent.com/trials/role-of-early-versus-late-switch-to-lapatinib-capecitabine-tyco-38483https://curecurrent.com/trials/bioequivalence-study-of-ig-001-versus-nab-paclitaxel-in-metastatic-or-locally-recurrent-breast-cancer-38484https://curecurrent.com/trials/breathe-for-hot-flashes-randomized-controlled-trial-38485https://curecurrent.com/trials/the-registration-program-of-brca1-2-gene-38486https://curecurrent.com/trials/debio-1143-in-combination-with-carboplatin-and-paclitaxel-in-patient-with-advanced-solid-malignancies-38487https://curecurrent.com/trials/the-effects-of-indocyanine-green-angiography-iga-on-deep-inferior-epigastric-artery-perforator-diep-flap-design-and-post-38488https://curecurrent.com/trials/breast-cancer-risk-assessment-using-optical-breast-spectroscopy-obs-38489https://curecurrent.com/trials/a-study-to-evaluate-renal-safety-of-intravenous-ibandronate-bondronat-in-participants-with-metastatic-bone-disease-due-t-38490https://curecurrent.com/trials/monitoring-of-breast-tissue-change-due-to-hormone-replacement-therapy-in-post-menopausal-women-using-obs-38491https://curecurrent.com/trials/temperature-sensitive-liposomal-doxorubicin-and-hyperthermia-in-treating-women-with-locally-recurrent-breast-cancer-38492https://curecurrent.com/trials/neoadjuvant-study-with-chemotherapy-lapatinib-and-trastuzumab-in-breast-cancer-38493https://curecurrent.com/trials/tivantinib-in-treating-patients-with-recurrent-or-metastatic-breast-cancer-38494https://curecurrent.com/trials/edema-control-in-patients-with-breast-cancer-comparison-of-manual-lymph-drainage-and-epidermis-fascia-taping-38495https://curecurrent.com/trials/bevacizumab-paclitaxel-capecitabine-in-triple-negative-metastatic-breast-cancer-38496https://curecurrent.com/trials/first-line-metastatic-breast-cancer-treatment-esmeralda-38497https://curecurrent.com/trials/a-phase-2-study-of-standard-chemotherapy-plus-bsi-201-a-parp-inhibitor-in-the-neoadjuvant-treatment-of-triple-negative-b-38498https://curecurrent.com/trials/a-study-evaluating-iniparib-in-combination-with-chemotherapy-to-treat-triple-negative-breast-cancer-brain-metastasis-38499https://curecurrent.com/trials/non-invasive-imaging-for-cording-in-breast-cancer-patients-38500https://curecurrent.com/trials/a-study-of-gene-polymorphisms-and-normal-tissue-radiation-injury-in-patients-treated-for-breast-prostate-brain-lung-and-38501https://curecurrent.com/trials/weekly-doses-of-cilengitide-and-paclitaxel-in-treating-patients-with-advanced-solid-tumors-that-cannot-be-removed-by-sur-38502https://curecurrent.com/trials/aprepitant-granisetron-dexamethasone-in-preventing-nausea-vomiting-in-pts-receiving-cyclophosphamide-before-a-stem-cell-38503https://curecurrent.com/trials/a-study-to-assess-the-ability-of-a-novel-endocrine-treatment-for-breast-cancer-irosustat-to-slow-down-cancer-growth-38504https://curecurrent.com/trials/exemestane-plus-goserelin-in-treating-premenopausal-women-with-metastatic-breast-cancer-38505https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-breast-cancer-38506https://curecurrent.com/trials/a-phase-ii-combination-of-trastuzumab-and-ixabepilone-versus-trastuzumab-and-docetaxel-in-patients-with-advanced-and-or-38507https://curecurrent.com/trials/randomized-phase-ii-study-of-ixabepilone-alone-and-ixabepilone-plus-cetuximab-as-first-line-treatment-for-female-subject-38508https://curecurrent.com/trials/phase-i-study-of-ixabepilone-plus-lapatinib-with-or-without-capecitabine-in-the-treatment-of-human-epidermal-growth-fact-38509https://curecurrent.com/trials/ixabepilone-and-liposomal-doxorubicin-in-advanced-ovarian-cancer-38510https://curecurrent.com/trials/a-trial-of-2-schedules-of-ixabepilone-plus-bevacizumab-and-paclitaxel-plus-bevacizumab-for-breast-cancer-38511https://curecurrent.com/trials/a-phase-i-study-of-ixabepilone-in-combination-with-capecitabine-in-japanese-patients-with-metastatic-breast-cancer-38512https://curecurrent.com/trials/randomized-study-evaluating-ixabepilone-plus-capecitabine-or-docetaxel-plus-capecitabine-in-metastatic-breast-cancer-38513https://curecurrent.com/trials/phase-i-combination-w-epirubicin-38514https://curecurrent.com/trials/phase-ii-trial-of-weekly-or-every-3-week-ixabepilone-for-patients-with-metastatic-breast-cancer-38515https://curecurrent.com/trials/telephone-based-educational-intervention-in-improving-communication-between-patients-with-stage-0-iii-cancer-and-their-c-38516https://curecurrent.com/trials/focused-ultrasound-surgery-in-the-treatment-of-pain-resulting-from-metastatic-bone-tumors-with-the-exablate-2100-conform-38517https://curecurrent.com/trials/physical-activity-fatigue-sleep-and-inflammation-38518https://curecurrent.com/trials/oral-curcumin-for-radiation-dermatitis-38519https://curecurrent.com/trials/observational-study-to-evaluate-mechanisms-of-aromatase-inhibitor-associated-musculoskeletal-symptoms-38520https://curecurrent.com/trials/adjuvant-hypofractionated-intensity-modulated-radiation-therapy-with-incorporated-boost-in-treating-patients-with-early-38521https://curecurrent.com/trials/ptc299-and-hormonal-agent-for-treatment-of-metastatic-breast-cancer-38522https://curecurrent.com/trials/efficacy-and-optimal-dose-selection-of-intranasal-dexmedetomidine-during-breast-lumpectomy-under-local-anaesthesia-38523https://curecurrent.com/trials/a-phase-ib-expansion-study-investigating-the-safety-efficacy-and-pharmacokinetics-of-intravenous-cudc-101-in-subjects-wi-38524https://curecurrent.com/trials/prospective-study-of-health-in-runners-and-walkers-38525https://curecurrent.com/trials/study-of-biomarkers-in-tissue-samples-from-patients-with-breast-cancer-38526https://curecurrent.com/trials/compassionate-same-day-evaluation-delivery-of-xrt-for-bony-metastasis-in-hospice-patients-38527https://curecurrent.com/trials/ketogenic-or-logi-diet-in-a-breast-cancer-rehabilitation-intervention-kolibri-38528https://curecurrent.com/trials/an-investigation-of-the-effect-of-the-promoter-polymorphism-in-the-glucuronosyltransferase-2b7-in-patients-on-breast-can-38529https://curecurrent.com/trials/lapatinib-in-combination-with-trastuzumab-versus-lapatinib-monotherapy-in-subjects-with-her2-positive-metastatic-breast-38530https://curecurrent.com/trials/hepasphere-interventional-therapy-using-digital-subtraction-angiography-dsa-for-breast-cancer-38531https://curecurrent.com/trials/prospective-retrospective-data-collection-of-breast-cancer-cases-from-2000-to-present-38532https://curecurrent.com/trials/changes-in-biomarkers-of-cancer-in-women-with-breast-cancer-and-without-evidence-of-disease-who-were-given-phytomed-38533https://curecurrent.com/trials/pazopanib-plus-lapatinib-compared-to-lapatinib-alone-in-subjects-with-advanced-or-metastatic-breast-cancer-38534https://curecurrent.com/trials/administration-during-chemotherapy-to-reduce-ovarian-failure-following-chemotherapy-in-early-stage-hormone-receptor-nega-38535https://curecurrent.com/trials/study-to-assess-effectiveness-of-giving-combination-of-standard-chemotherapy-drugs-versus-combination-of-standard-chemot-38536https://curecurrent.com/trials/trial-of-mesna-to-prevent-doxorubicin-induced-plasma-protein-oxidation-and-tumor-necrosis-factor-alpha-tnf-release-38537https://curecurrent.com/trials/novel-surrogate-markers-as-predictors-of-radiation-toxicity-in-breast-cancer-patients-undergoing-helical-tomotherapy-com-38538https://curecurrent.com/trials/frequency-of-portal-images-required-to-enhance-quality-assurance-for-breast-cancer-patients-treated-with-radiotherapy-38539https://curecurrent.com/trials/immunotherapy-combined-with-capecitabine-versus-capecitabine-monotherapy-in-advanced-breast-cancer-38540https://curecurrent.com/trials/the-use-of-metformin-in-early-breast-cancer-patients-pre-surgery-38541https://curecurrent.com/trials/study-of-human-epidermal-growth-receptor-her2-status-evaluation-in-breast-cancer-pathology-samples-38542https://curecurrent.com/trials/feasibility-assessment-of-a-patients-follow-up-visit-receiving-trastuzumab-subcutaneous-by-advanced-practice-nurse-38543https://curecurrent.com/trials/neoadjuvant-chemotherapy-docetaxel-with-or-without-selumetinib-in-patients-with-triple-negative-breast-cancer-38544https://curecurrent.com/trials/green-tea-and-reduction-of-breast-cancer-risk-38545https://curecurrent.com/trials/automated-tele-counseling-for-screening-mammography-38546https://curecurrent.com/trials/phase-ii-trial-of-stereotactic-radiosurgery-boost-following-surgical-resection-for-brain-metastases-38547https://curecurrent.com/trials/an-observational-study-of-avastin-bevacizumab-in-patients-with-metastatic-breast-cancer-38548https://curecurrent.com/trials/an-observational-follow-up-study-of-1st-line-treatment-with-herceptin-trastuzumab-in-patients-with-metastatic-breast-can-38549https://curecurrent.com/trials/the-impact-of-obesity-and-obesity-treatments-on-breast-cancer-38550https://curecurrent.com/trials/bone-response-in-metastatic-breast-cancer-involving-bones-38551https://curecurrent.com/trials/lonafarnib-in-metastatic-breast-cancer-38552https://curecurrent.com/trials/tori-104-pre-surgical-dasatinib-38553https://curecurrent.com/trials/biological-therapy-in-treating-women-with-stage-iv-breast-cancer-38554https://curecurrent.com/trials/prospective-chart-review-impact-of-combination-digital-breast-tomosynthesis-digital-mammography-38555https://curecurrent.com/trials/erlotinib-plus-docetaxel-in-treating-patients-with-stage-iv-or-recurrent-breast-cancer-38556https://curecurrent.com/trials/leuprorelin-acetate-sr-11-25-mg-for-injection-specified-drug-use-survey-long-term-use-survey-on-premenopausal-breast-can-38557https://curecurrent.com/trials/chemotherapy-followed-by-peripheral-stem-cell-transplantation-plus-biological-therapy-in-treating-women-with-stage-iv-br-38558https://curecurrent.com/trials/using-a-dissolved-oxygen-enriched-dressing-in-nipple-sparing-mastectomy-38559https://curecurrent.com/trials/addition-of-carboplatin-to-neoadjuvant-therapy-for-triple-negative-and-her2-positive-early-breast-cancer-38560https://curecurrent.com/trials/olaparib-in-locally-advanced-er-pgr-and-her2-negative-triple-negative-and-in-locally-advanced-germline-brca-mutation-pos-38561https://curecurrent.com/trials/investigation-of-the-pain-relieving-properties-of-lipotransplantation-after-treatment-for-breast-cancer-38562https://curecurrent.com/trials/preoperative-epirubicin-paclitaxel-aranesp-study-prepare-38563https://curecurrent.com/trials/lapatinib-and-epirubicin-in-treating-patients-with-metastatic-breast-cancer-icorg-06-30-38564https://curecurrent.com/trials/dichloroacetate-dca-in-patients-with-previously-treated-metastatic-breast-or-non-small-cell-lung-cancer-nscl-38565https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-chemotherapy-in-patients-with-breast-cancer-progressing-after-first-l-38566https://curecurrent.com/trials/safety-and-efficacy-of-azd4547-in-combination-with-fulvestrant-vs-fulvestrant-alone-in-er-breast-cancer-patients-38567https://curecurrent.com/trials/imaging-biomarker-for-early-detection-of-treatment-efficacy-during-breast-cancer-neoadjuvant-chemotherapy-38568https://curecurrent.com/trials/everolimus-beyond-progress-for-patients-who-had-progress-under-everolimus-and-exemestane-38569https://curecurrent.com/trials/adjuvant-chemotherapy-for-elderly-non-frail-patients-with-an-increased-risk-for-relapse-of-a-primary-carcinoma-of-the-br-38570https://curecurrent.com/trials/ox-40-protein-expression-in-the-sentinel-lymph-nodes-of-patients-with-cancer-38571https://curecurrent.com/trials/factors-and-perceptions-affecting-treatment-choices-of-breast-cancer-patients-38572https://curecurrent.com/trials/bevacizumab-everolimus-rad001-and-lapatinib-as-neoadjuvant-chemotherapy-regimes-for-primary-breast-cancer-38573https://curecurrent.com/trials/a-phase-ii-trial-of-doxorubicin-and-genexol-pm-in-patients-with-advanced-breast-cancer-38574https://curecurrent.com/trials/efficacy-and-tolerability-of-eribulin-plus-lapatinib-in-patients-with-metastatic-breast-cancer-e-vita-38575https://curecurrent.com/trials/vegetable-garden-feasibility-trial-to-promote-function-in-older-cancer-survivors-38576https://curecurrent.com/trials/a-study-of-bind-014-given-to-patients-with-advanced-or-metastatic-cancer-38577https://curecurrent.com/trials/multidisciplinary-approach-to-novel-therapies-in-cardiology-oncology-research-38578https://curecurrent.com/trials/compliance-to-a-hormone-therapy-regimen-in-breast-cancer-38579https://curecurrent.com/trials/mentor-integration-study-38580https://curecurrent.com/trials/sorafenib-and-letrozole-anastrozole-or-exemestane-in-treating-postmenopausal-women-with-estrogen-receptor-positive-and-o-38581https://curecurrent.com/trials/clinical-application-of-dual-sentinel-lymph-node-staining-method-in-breast-cancer-38582https://curecurrent.com/trials/avareg-study-an-observational-study-of-avastin-bevacizumab-in-patients-with-metastatic-breast-cancer-38583https://curecurrent.com/trials/feasibility-study-of-presurgical-hormone-therapy-anastrozole-in-breast-cancer-patients-38584https://curecurrent.com/trials/proton-mr-spectroscopy-and-18f-fluorocholine-pet-for-breast-cancer-diagnosis-38585https://curecurrent.com/trials/calcium-and-magnesium-in-preventing-peripheral-neuropathy-caused-by-ixabepilone-in-patients-with-breast-cancer-38586https://curecurrent.com/trials/lymphedema-therapy-with-sound-wave-lymphatic-drainage-38587https://curecurrent.com/trials/utility-and-work-productivity-data-for-economic-evaluation-of-breast-cancer-therapies-in-the-netherlands-and-sweden-38588https://curecurrent.com/trials/effects-of-vitamin-d-in-patients-with-breast-cancer-38589https://curecurrent.com/trials/couple-focused-intervention-for-breast-cancer-patients-38590https://curecurrent.com/trials/fat-metabolism-following-chemotherapy-in-breast-cancer-38591https://curecurrent.com/trials/phase-i-study-to-evaluate-safety-tolerability-anti-tumour-activity-and-pk-profiles-of-foxy-5-in-metastatic-breast-colon-38592https://curecurrent.com/trials/a-study-of-lapatinib-in-combination-with-caelyx-in-patients-with-advanced-her2-positive-pretreated-breast-cancer-38593https://curecurrent.com/trials/mutation-of-brca1-2-and-other-potential-genes-in-triple-negative-breast-cancer-38594https://curecurrent.com/trials/diet-and-estrogen-metabolism-in-postmenopausal-women-38595https://curecurrent.com/trials/prospective-study-of-mammaprint-in-patients-with-an-intermediate-recurrence-score-38596https://curecurrent.com/trials/use-of-pro-onc-assay-to-assess-her2-in-patients-with-metastatic-breast-cancer-38597https://curecurrent.com/trials/investigating-the-use-of-drains-and-internal-quilting-sutures-on-seroma-formation-following-mastectomy-38598https://curecurrent.com/trials/evaluation-of-breast-cancer-surgical-margins-using-optical-spectroscopy-38599https://curecurrent.com/trials/autologous-natural-killer-t-cells-infusion-for-the-treatment-of-cancer-38600https://curecurrent.com/trials/clinical-outcomes-in-hereditary-cancer-38601https://curecurrent.com/trials/a-study-of-bevacizumab-avastin-in-women-with-her2-negative-metastatic-breast-cancer-38602https://curecurrent.com/trials/biweekly-docetaxel-in-patients-with-metastatic-breast-cancer-38603https://curecurrent.com/trials/visualization-of-the-effect-of-acupuncture-on-brain-serotonin-in-breast-cancer-survivors-38604https://curecurrent.com/trials/evaluation-of-the-diagnostic-performance-of-mri-biopsy-to-optimize-resection-of-ductal-carcinoma-in-situ-dcis-breast-can-38605https://curecurrent.com/trials/an-observational-study-of-avastin-bevacizumab-in-patients-with-her2-metastatic-or-locally-advanced-breast-cancer-38606https://curecurrent.com/trials/imetelstat-in-combination-with-paclitaxel-with-or-without-bevacizumab-in-patients-with-locally-recurrent-or-metastatic-b-38607https://curecurrent.com/trials/case-control-study-on-the-breast-cancer-risk-of-mirena-compared-with-copper-iuds-38608https://curecurrent.com/trials/a-trial-of-the-forecyte-breast-aspirator-for-cytological-testing-of-nipple-aspirate-fluid-in-women-30-55-years-old-38609https://curecurrent.com/trials/study-of-biweekly-capecitabine-dosing-with-bevacizumab-for-the-treatment-of-metastatic-breast-cancer-based-upon-the-nort-38610https://curecurrent.com/trials/docetaxel-carboplatin-and-trastuzumab-and-or-lapatinib-in-treating-women-with-stage-i-stage-ii-or-stage-iii-breast-cance-38611https://curecurrent.com/trials/the-use-of-smart-scales-for-weight-gain-prevention-in-african-american-breast-cancer-survivors-38612https://curecurrent.com/trials/a-single-session-intervention-for-fear-of-recurrence-in-breast-cancer-patients-38613https://curecurrent.com/trials/phase-i-ii-azd8931-paclitaxel-in-treatment-of-advanced-solid-tumours-phase-i-and-advanced-breast-cancer-phase-ii-38614https://curecurrent.com/trials/mammography-reminders-for-encouraging-women-to-undergo-regular-mammography-screenings-for-breast-cancer-38615https://curecurrent.com/trials/group-based-lifestyle-intervention-in-measuring-biomarker-levels-in-participants-at-high-risk-for-breast-cancer-38616https://curecurrent.com/trials/cancer-screening-program-for-women-at-high-risk-for-developing-ovarian-cancer-38617https://curecurrent.com/trials/assessing-the-patient-experience-in-cancer-care-38618https://curecurrent.com/trials/safety-study-of-an-antisense-product-in-prostate-ovarian-nscl-breast-or-bladder-cancer-38619https://curecurrent.com/trials/cariatide-compliance-of-aromatase-inhibitors-assessment-in-daily-practice-through-educational-approach-38620https://curecurrent.com/trials/enhancing-exercise-in-breast-cancer-survivors-38621https://curecurrent.com/trials/safety-and-efficacy-of-lapatinib-plus-trastuzumab-or-lapatinib-plus-capecitabine-in-metastatic-breast-cancer-38622https://curecurrent.com/trials/breast-10-three-weekly-versus-weekly-first-line-chemotherapy-for-metastatic-or-locally-advanced-breast-cancer-38623https://curecurrent.com/trials/agatolimod-and-trastuzumab-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-38624https://curecurrent.com/trials/semi-quantification-of-her2-neu-protein-expression-in-formalin-fixed-paraffin-embedded-normal-and-neoplastic-tissue-38625https://curecurrent.com/trials/identification-and-semi-quantification-of-er-pr-proteins-expression-38626https://curecurrent.com/trials/koning-breast-computed-tomography-guided-neoadjuvant-treatment-monitoring-38627https://curecurrent.com/trials/identification-and-semi-quantification-of-ki-67-protein-expression-status-38628https://curecurrent.com/trials/genesearch-breast-lymph-node-bln-assay-timing-study-38629https://curecurrent.com/trials/validation-study-using-the-genesearch-bln-assay-to-test-sentinel-lymph-nodes-from-patients-with-breast-cancer-38630https://curecurrent.com/trials/effects-of-short-term-fasting-on-tolerance-to-chemotherapy-38631https://curecurrent.com/trials/genesearch-breast-lymph-node-bln-assay-post-approval-study-38632https://curecurrent.com/trials/line-treatment-patterns-in-postmenopausal-women-with-hormone-receptor-positive-breast-cancer-38633https://curecurrent.com/trials/multi-level-evaluation-of-chemotherapy-induced-febrile-neutropenia-prophylaxis-outcomes-and-determinants-with-granulocyt-38634https://curecurrent.com/trials/the-effect-of-combined-decongestive-therapy-and-pneumatic-compression-pump-on-body-image-in-patients-with-lymphedema-38635https://curecurrent.com/trials/assessment-of-the-decision-making-impact-of-the-breast-cancer-index-in-recommending-extended-adjuvant-endocrine-therapy-38636https://curecurrent.com/trials/the-effect-of-dexmedetomidine-of-the-immune-system-38637https://curecurrent.com/trials/thalidomide-plus-chemotherapy-versus-chemotherapy-alone-for-advanced-breast-cancer-38638https://curecurrent.com/trials/pre-operative-single-dose-ipilimumab-and-or-cryoablation-in-early-stage-resectable-breast-cancer-38639https://curecurrent.com/trials/immunohistochemical-ihc-scoring-for-receptors-expression-in-breast-tissues-38640https://curecurrent.com/trials/myocet-cyclophosphamide-metformin-vs-myocet-cyclophosphamide-in-1st-line-treatment-of-her2-neg-metastatic-breast-cancer-38641https://curecurrent.com/trials/a-pharmacodynamics-pre-surgical-study-of-lee011-in-early-breast-cancer-patients-monaleesa-1-38642https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-at-high-risk-for-breast-cancer-recurrence-38643https://curecurrent.com/trials/the-detection-of-circulating-tumor-cells-ctcs-in-patients-with-breast-cancer-undergoing-cryosurgery-combined-with-dc-cik-38644https://curecurrent.com/trials/danish-observational-study-of-everolimus-plus-exemestane-in-hormone-receptor-hr-positive-human-epidermal-growth-factor-2-38645https://curecurrent.com/trials/fulvestrant-combined-anastrozole-versus-anastrozole-in-luminal-a-like-postmenopausal-abc-38646https://curecurrent.com/trials/safety-study-of-modified-vaccinia-virus-to-cancer-38647https://curecurrent.com/trials/support-and-rehabilitation-protocol-for-non-metastatic-breast-cancer-patients-in-complete-remission-after-chemotherapy-38648https://curecurrent.com/trials/pet-imaging-with-cu-64-labeled-trastuzumab-in-her2-metastatic-breast-cancer-38649https://curecurrent.com/trials/adaptated-physical-activity-in-cancerology-38650https://curecurrent.com/trials/spectroscopy-with-surface-coils-and-decoupling-38651https://curecurrent.com/trials/efficacy-and-safety-of-everolimus-in-combination-therapy-in-patients-with-her2-overexpressing-metastatic-breast-cancer-38652https://curecurrent.com/trials/gene-expression-following-short-term-exposure-to-neoadjuvant-endocrine-therapy-in-invasive-breast-cancer-38653https://curecurrent.com/trials/pet-scans-in-patients-with-locally-advanced-breast-cancer-38654https://curecurrent.com/trials/a-study-of-grn163l-with-paclitaxel-and-bevacizumab-to-treat-patients-with-locally-recurrent-or-metastatic-breast-cancer-38655https://curecurrent.com/trials/investigation-of-changes-in-bone-scan-imaging-before-and-after-intravenous-bisphosphonate-therapy-for-osseous-metastases-38656https://curecurrent.com/trials/positron-emission-tomography-before-surgery-in-evaluating-women-with-primary-or-recurrent-breast-cancer-38657https://curecurrent.com/trials/histologic-assessment-of-the-difference-between-18f-2-fluoro-2-deoxy-d-glucose-positron-emission-mammography-pem-and-mag-38658https://curecurrent.com/trials/celecoxib-in-preventing-hand-foot-syndrome-caused-by-capecitabine-with-metastatic-breast-or-colorectal-cancer-38659https://curecurrent.com/trials/feasibility-testing-and-evaluation-of-an-online-toolkit-for-male-spouses-of-women-with-breast-cancer-38660https://curecurrent.com/trials/dose-dense-epirubicin-and-cyclophosphamide-ec-followed-by-paclitaxel-in-breast-cancer-feasibility-38661https://curecurrent.com/trials/tobacco-dependence-in-breast-cancer-patients-trial-of-varenicline-chantix-38662https://curecurrent.com/trials/quadrant-high-dose-rate-intraoperative-radiation-therapy-iort-for-early-stage-breast-cancer-a-pilot-study-38663https://curecurrent.com/trials/vinorelbine-plus-capecitabine-versus-docetaxel-plus-capecitabine-in-anthracycline-pretreated-women-with-metastatic-breas-38664https://curecurrent.com/trials/steroid-aromatase-inhibitors-versus-progestogens-for-nsaid-resistanced-late-stage-breast-cancer-38665https://curecurrent.com/trials/trial-of-gemcitabine-capecitabine-versus-gemcitabine-carboplatin-in-breast-cancer-38666https://curecurrent.com/trials/paclitaxel-in-combination-with-carboplatin-versus-paclitaxel-plus-epirubicin-in-metastatic-breast-cancer-38667https://curecurrent.com/trials/the-diagnostic-technology-applied-research-of-cdk5rap2-in-breast-cancer-38668https://curecurrent.com/trials/phase-ii-trial-of-neoadjuvant-fec100-cisplatin-docetaxel-trastuzumab-in-women-with-over-expressed-or-amplified-her2-neu-38669https://curecurrent.com/trials/measuring-musculoskeletal-symptoms-in-patients-receiving-aromatase-inhibitors-38670https://curecurrent.com/trials/effects-of-zometa-and-physical-activity-on-bone-density-in-women-receiving-chemotherapy-for-breast-cancer-38671https://curecurrent.com/trials/a-phase-i-safety-study-of-a-cancer-vaccine-to-treat-hla-a2-positive-advanced-stage-ovarian-breast-and-prostate-cancer-38672https://curecurrent.com/trials/positron-emission-tomography-in-monitoring-treatment-response-in-women-with-newly-diagnosed-breast-cancer-38673https://curecurrent.com/trials/qigong-for-breast-cancer-survivors-38674https://curecurrent.com/trials/capecitabine-as-neoadjuvant-therapy-in-locally-advanced-breast-cancer-38675https://curecurrent.com/trials/trial-to-evaluate-genomic-expression-profiles-to-direct-preoperative-chemotherapy-in-early-stage-breast-cancer-38676https://curecurrent.com/trials/presurgical-therapy-with-lapatinib-to-explore-molecular-determinants-of-response-to-egfr-erbb2-targeted-therapy-38677https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-or-without-huaier-granule-in-treating-women-with-locally-advanced-breast-cancer-that-can-b-38678https://curecurrent.com/trials/randomized-controlled-single-blind-trial-to-evaluate-the-mobile-tracking-of-symptoms-in-ambulatory-breast-cancer-patient-38679https://curecurrent.com/trials/docetaxel-vinorelbine-and-trastuzumab-in-the-treatment-of-patients-with-metastatic-her-2-positive-breast-cancer-38680https://curecurrent.com/trials/evaluation-of-a-new-agent-for-treatment-of-advanced-stage-breast-cancer-38681https://curecurrent.com/trials/lactation-outcomes-among-survivors-of-pediatric-cancer-38682https://curecurrent.com/trials/optimizing-the-delineation-of-the-tumour-bed-in-breast-irradiation-38683https://curecurrent.com/trials/assessment-of-progesterone-receptors-in-breast-carcinoma-by-positron-emission-tomography-pet-using-fluoro-furanyl-norpro-38684https://curecurrent.com/trials/capecitabine-and-oxaliplatin-in-treating-patients-with-metastatic-breast-cancer-38685https://curecurrent.com/trials/a-correlative-study-for-predicting-response-and-toxicity-in-patients-receiving-chemotherapy-for-breast-cancer-38686https://curecurrent.com/trials/explore-the-individual-treatment-of-docetaxel-and-paclitaxel-in-nsclc-npc-and-brc-by-pk-guided-dosing-strategy-38687https://curecurrent.com/trials/ptk787-trastuzumab-for-her2-overexpressing-metastatic-breast-cancer-38688https://curecurrent.com/trials/cosmetic-evaluation-of-lumpectomy-versus-oncolytic-mammoplasty-with-bilateral-breast-reduction-for-early-stage-breast-ca-38689https://curecurrent.com/trials/cathepsin-activatable-fluorescent-probe-38690https://curecurrent.com/trials/epigenetics-and-psychoneurologic-symptoms-in-women-with-breast-cancer-38691https://curecurrent.com/trials/a-phase-ii-study-of-azd2171-in-breast-cancer-stage-iv-10006202-38692https://curecurrent.com/trials/imiquimod-for-breast-cancer-patients-with-chest-wall-recurrence-or-skin-metastases-38693https://curecurrent.com/trials/stress-management-in-breast-cancer-patients-38694https://curecurrent.com/trials/a-pivotal-bioequivalence-study-of-doxil-caelyx-doxorubicin-hcl-in-patients-with-advanced-or-refractory-solid-malignancie-38695https://curecurrent.com/trials/a-lifestyle-intervention-for-breast-cancer-survivors-38696https://curecurrent.com/trials/oncoplastic-breast-conserving-surgery-in-non-metastatic-breast-cancer-patients-38697https://curecurrent.com/trials/pemetrexed-disodium-and-docetaxel-in-treating-patients-with-advanced-solid-tumors-38698https://curecurrent.com/trials/self-reported-exercise-behavior-and-short-term-patient-outcomes-in-women-undergoing-radiation-treatment-for-operable-bre-38699https://curecurrent.com/trials/predictors-of-lymphedema-following-breast-cancer-surgery-38700https://curecurrent.com/trials/dose-response-curve-interventions-to-prevent-and-treat-radiodermatitis-38701https://curecurrent.com/trials/spot-tm-tattooing-of-biopsied-axillary-lymph-nodes-with-ultrasound-guided-in-breast-cancer-patients-prior-to-surgery-38702https://curecurrent.com/trials/tomosynthesis-ts-versus-ultrasonography-us-in-women-with-dense-breast-38703https://curecurrent.com/trials/the-women-s-healthy-lifestyle-study-38704https://curecurrent.com/trials/evaluation-of-therapeutic-efficacy-in-use-of-chamomilla-gel-chamomilla-infuse-and-urea-in-radiodermatitis-38705https://curecurrent.com/trials/safety-and-tolerability-of-everolimus-in-combination-with-eribulin-in-triple-negative-breast-cancers-38706https://curecurrent.com/trials/diagnostic-study-of-early-breast-cancer-using-ultrasound-38707https://curecurrent.com/trials/partial-breast-irradiation-for-low-risk-ductal-carcinoma-in-situ-after-breast-conserving-surgery-38708https://curecurrent.com/trials/the-effects-of-circadian-gene-on-sleep-and-associated-symptoms-in-breast-cancer-patients-under-chemotherapy-38709https://curecurrent.com/trials/feasibility-of-a-team-approach-for-discussing-prognosis-and-treatment-goals-in-breast-cancer-38710https://curecurrent.com/trials/exercise-to-prevent-aromatase-inhibitor-side-effects-in-breast-cancer-patients-38711https://curecurrent.com/trials/huaier-granule-in-treating-women-with-triple-negative-breast-cancer-38712https://curecurrent.com/trials/a-phase-3-comparative-study-of-tap-144-sr-6m-in-postoperative-and-hormone-therapy-na-ve-patients-with-premenopausal-brea-38713https://curecurrent.com/trials/sm-edtmp-and-autologous-peripheral-blood-stem-cell-transplantation-for-breast-cancer-patients-with-bone-only-metastases-38714https://curecurrent.com/trials/study-of-panobinostat-monotherapy-in-women-with-v-erb-b2-avian-erythroblastic-leukemia-viral-oncogene-homolog-2-her2-pos-38715https://curecurrent.com/trials/pilot-study-of-radiofrequency-ablation-of-breast-cancer-lumpectomy-sites-to-decrease-re-operation-38716https://curecurrent.com/trials/comparative-analysis-of-the-efficacies-in-neoadjuvant-chemotherapy-of-breast-cancer-38717https://curecurrent.com/trials/sienna-injection-time-study-4-arms-38718https://curecurrent.com/trials/cranial-stimulation-for-chemotherapy-symptoms-in-breast-cancer-38719https://curecurrent.com/trials/axillary-radiotherapy-for-early-stage-breast-cancer-with-limited-positive-sentinel-lymph-nodes-38720https://curecurrent.com/trials/irinotecan-and-etoposide-in-treating-patients-with-recurrent-locally-advanced-or-metastatic-breast-cancer-38721https://curecurrent.com/trials/the-impact-of-physical-activity-on-the-outcome-of-surgery-38722https://curecurrent.com/trials/open-label-study-of-sta-9090-for-patients-with-metastatic-breast-cancer-38723https://curecurrent.com/trials/comparison-of-pem-uptake-value-puv-and-standardized-uptake-value-suv-in-patients-with-malignancies-of-the-breast-38724https://curecurrent.com/trials/prospective-trial-of-vaccine-responses-against-pneumococcus-and-influenza-in-adult-cancer-patients-65-years-of-age-and-o-38725https://curecurrent.com/trials/immediate-axillary-plasty-with-a-pedicled-muscle-flap-for-breast-cancer-related-lymphedema-prevention-38726https://curecurrent.com/trials/upper-extremity-lymphatic-mapping-for-breast-cancer-patients-38727https://curecurrent.com/trials/selective-image-guided-resection-of-axillary-lymph-nodes-38728https://curecurrent.com/trials/s9626-megestrol-in-treating-hot-flashes-following-treatment-for-breast-cancer-38729https://curecurrent.com/trials/b-receptor-signaling-in-cardiomyopathy-38730https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-bone-metastases-from-breast-or-prostate-cancer-38731https://curecurrent.com/trials/quality-of-life-in-african-american-or-caucasian-female-breast-cancer-survivors-38732https://curecurrent.com/trials/detection-of-flap-ischemia-using-interstitial-glucose-monitor-38733https://curecurrent.com/trials/peripheral-stem-cell-transplantation-in-treating-patients-with-melanoma-or-small-cell-lung-breast-testicular-or-kidney-c-38734https://curecurrent.com/trials/aspirin-on-ctcs-of-advanced-breast-and-colorectal-cancer-38735https://curecurrent.com/trials/capecitabine-in-women-with-operable-breast-cancer-38736https://curecurrent.com/trials/prevention-of-delayed-nausea-a-phase-iii-double-blind-placebo-controlled-clinical-trial-38737https://curecurrent.com/trials/treatment-decision-making-between-oncologists-and-women-with-newly-diagnosed-breast-cancer-and-their-healthy-companions-38738https://curecurrent.com/trials/irradiated-donor-lymphocyte-infusion-in-treating-patients-with-relapsed-or-refractory-hematologic-cancer-or-solid-tumor-38739https://curecurrent.com/trials/emg-at-performing-ultn-1-in-breast-cancer-patients-38740https://curecurrent.com/trials/tme-neoadjuvant-breast-registry-38741https://curecurrent.com/trials/phase-i-ii-study-of-vorinostat-paclitaxel-and-bevacizumab-in-metastatic-breast-cancer-38742https://curecurrent.com/trials/an-open-label-multicenter-phase-2-window-of-opportunity-study-evaluating-ganetespib-in-women-with-breast-cancer-38743https://curecurrent.com/trials/evaluation-of-nutrition-and-metabolism-in-breast-cancer-patients-38744https://curecurrent.com/trials/clinical-value-of-89zr-trastuzumab-pet-38745https://curecurrent.com/trials/clinical-trial-of-intravenous-alvespimycin-in-patients-with-her2-positive-breast-cancer-38746https://curecurrent.com/trials/systemic-dickkopf-related-protein-1-dkk1-during-estrogen-level-changes-in-post-menopausal-breast-cancer-patients-treated-38747https://curecurrent.com/trials/clinical-trial-of-the-combination-of-trastuzumab-herceptin-and-tanespimycin-in-patients-with-solid-tumors-and-her2-posit-38748https://curecurrent.com/trials/treatment-with-ribavirin-for-patients-with-metastatic-breast-cancer-38749https://curecurrent.com/trials/zoledronic-acid-as-adjuvant-treatment-of-triple-negative-breast-cancer-38750https://curecurrent.com/trials/brca1-associated-dna-repair-dysfunction-in-patients-with-early-triple-negative-breast-cancer-treated-with-neoadjuvant-pl-38751https://curecurrent.com/trials/breast-surgery-recovery-the-clinical-and-psychosocial-impact-of-theya-recovery-range-38752https://curecurrent.com/trials/nipple-delay-prior-to-nipple-sparing-mastectomy-a-pilot-rct-38753https://curecurrent.com/trials/expressive-writing-and-adjustment-to-metastatic-breast-cancer-38754https://curecurrent.com/trials/phase-2-study-of-amg-386-plus-paclitaxel-with-or-without-bevacizumab-as-first-line-therapy-in-her2-negative-breast-cance-38755https://curecurrent.com/trials/study-of-cp-751-871-in-combination-with-exemestane-in-postmenopausal-women-with-hormone-receptor-positive-advanced-breas-38756https://curecurrent.com/trials/prevalence-of-genetic-polymorphisms-in-genes-coding-for-tamoxifen-metabolising-enzymes-38757https://curecurrent.com/trials/an-observational-study-to-assess-response-to-tamoxifen-in-breast-cancer-patients-38758https://curecurrent.com/trials/choose-to-lose-for-women-weight-loss-to-reduce-breast-cancer-risk-factors-38759https://curecurrent.com/trials/randomized-phase-iii-study-of-exemestane-aromasin-for-5-years-versus-tamoxifen-for-2-5-to-3-years-followed-by-exemestane-38760https://curecurrent.com/trials/nerveblocks-for-persistent-pain-after-breast-cancer-surgery-38761https://curecurrent.com/trials/a-study-inhibiting-telomerase-to-reverse-trastuzumab-resistance-in-her2-breast-cancer-38762https://curecurrent.com/trials/facilitating-adjustment-in-low-income-black-women-with-breast-cancer-38763https://curecurrent.com/trials/the-myocet-lapatinib-study-icorg-10-03-v5-38764https://curecurrent.com/trials/s9719-gene-damage-following-chemotherapy-in-women-with-stage-ii-or-stage-iii-breast-cancer-38765https://curecurrent.com/trials/intensive-education-in-increasing-understanding-of-lymphedema-in-patients-with-breast-cancer-undergoing-surgery-38766https://curecurrent.com/trials/effect-of-exercise-training-in-autonomic-modulation-in-breast-cancer-patients-38767https://curecurrent.com/trials/taxane-chemotherapy-and-nail-toxicity-in-women-with-breast-cancer-stage-two-evaluation-of-interventions-38768https://curecurrent.com/trials/walking-affecting-immunology-and-quality-of-life-of-breast-cancer-patients-38769https://curecurrent.com/trials/placebo-controlled-trial-with-vitamin-d-to-prevent-worsening-relieve-aromatase-inhibitor-induced-musculoskeletal-symptom-38770https://curecurrent.com/trials/automated-breast-ultrasound-and-digital-breast-tomosynthesis-screening-compared-to-full-field-digital-mammography-in-wom-38771https://curecurrent.com/trials/effects-of-internet-support-for-cancer-patients-38772https://curecurrent.com/trials/a-clinical-trial-to-determine-the-most-suitable-dose-of-opb-111001-in-patients-with-advanced-cancer-38773https://curecurrent.com/trials/treatment-of-relapsed-and-or-chemotherapy-refractory-advanced-malignancies-by-cart-meso-38774https://curecurrent.com/trials/effect-of-perioperative-intravenous-lidocaine-infusion-and-magnesium-infusion-on-the-functional-recovery-after-general-a-38775https://curecurrent.com/trials/swog-9342-chemotherapy-in-treating-women-enrolled-in-the-swog-8897-clinical-trial-38776https://curecurrent.com/trials/scripps-polster-breast-care-center-investigational-genebank-38777https://curecurrent.com/trials/pulsed-electromagnetic-fields-pemf-and-post-axillary-surgery-morbidity-38778https://curecurrent.com/trials/brain-metastases-in-erbb2-positive-breast-cancer-38779https://curecurrent.com/trials/aerobic-exercise-resistance-exercise-or-flexibility-and-relaxation-training-in-inactive-older-female-breast-cancer-survi-38780https://curecurrent.com/trials/a-study-of-amg-706-or-bevacizumab-in-combination-with-paclitaxel-chemotherapy-as-treatment-for-breast-cancer-38781https://curecurrent.com/trials/a-prospective-observational-study-of-lymphedema-in-breast-cancer-with-axillary-lymph-node-dissection-38782https://curecurrent.com/trials/gabapentin-for-the-control-of-hot-flashes-in-women-with-breast-cancer-38783https://curecurrent.com/trials/fluoroestradiol-pet-imaging-in-predicting-response-to-hormone-therapy-of-breast-cancer-38784https://curecurrent.com/trials/collecting-information-from-patients-enrolled-in-the-breast-specialized-program-of-research-excellence-38785https://curecurrent.com/trials/morphine-for-the-treatment-of-pain-in-patients-with-breast-cancer-38786https://curecurrent.com/trials/interferon-alfa-in-treating-patients-with-stage-iv-solid-tumors-lymphoma-or-myeloma-38787https://curecurrent.com/trials/efficacy-and-safety-of-bms-690514-in-combination-with-letrozole-to-treat-metastatic-breast-cancer-38788https://curecurrent.com/trials/effect-of-surgery-radiation-therapy-chemotherapy-and-hormone-therapy-on-biomarkers-in-women-with-stage-i-stage-ii-stage-38789https://curecurrent.com/trials/feasibility-study-of-cavity-radiofrequency-ablation-in-ex-vivo-mastectomy-breast-tissue-38790https://curecurrent.com/trials/neoadjuvant-tac-plus-or-minus-bevacizumab-avf3299-38791https://curecurrent.com/trials/identifying-circulating-breast-cancer-cells-in-women-with-metastatic-breast-cancer-38792https://curecurrent.com/trials/stress-reduction-in-improving-quality-of-life-in-patients-with-recurrent-gynecologic-or-breast-cancer-38793https://curecurrent.com/trials/bevacizumab-in-combination-with-chemotherapy-in-the-neo-adjuvant-setting-for-her2-breast-cancer-38794https://curecurrent.com/trials/post-marketing-surveillance-study-to-observe-safety-and-efficacy-of-aromasin-in-the-patients-with-early-or-advanced-brea-38795https://curecurrent.com/trials/the-effect-of-soy-protein-on-post-breast-cancer-surgery-pain-38796https://curecurrent.com/trials/maintenance-bevacizumab-or-observation-after-taxane-based-first-line-chemotherapy-in-metastatic-breast-cancer-38797https://curecurrent.com/trials/myocet-plus-endoxan-for-older-patients-with-breast-cancer-38798https://curecurrent.com/trials/setup-variation-in-the-supraclavicular-lymph-nodes-treatment-in-breast-cancer-patients-38799https://curecurrent.com/trials/suction-drain-versus-the-use-of-adaptive-skin-sutures-after-mastectomy-axillary-lymphadenectomy-a-prospective-randomised-38800https://curecurrent.com/trials/liposomal-doxorubicin-and-docetaxel-in-her2-negative-metastatic-breast-cancer-38801https://curecurrent.com/trials/study-of-tamoxifen-and-raloxifene-star-for-the-prevention-of-breast-cancer-in-postmenopausal-women-38802https://curecurrent.com/trials/functional-anatomical-examination-of-axillary-sentinel-lymph-node-drainage-in-the-axillary-subregions-in-early-breast-ca-38803https://curecurrent.com/trials/cosmetic-and-functional-outcomes-after-breast-conserving-surgery-38804https://curecurrent.com/trials/aging-and-cancer-effects-ace-study-38805https://curecurrent.com/trials/pycnogenol-for-the-treatment-of-lymphedema-38806https://curecurrent.com/trials/phase-ii-metastatic-er-pgr-nolvadex-iressa-study-38807https://curecurrent.com/trials/fatigue-caused-by-chemotherapy-in-women-who-have-undergone-surgery-for-breast-cancer-and-in-healthy-volunteers-38808https://curecurrent.com/trials/views-on-sharing-family-medical-history-in-healthy-women-undergoing-mammograms-or-breast-evaluation-38809https://curecurrent.com/trials/arsenic-trioxide-in-treating-women-with-locally-advanced-or-metastatic-breast-cancer-38810https://curecurrent.com/trials/study-of-calgranulin-a-b-levels-in-patients-with-newly-diagnosed-stage-i-ii-iii-breast-cancer-38811https://curecurrent.com/trials/hormone-receptor-positive-metastatic-breast-cancer-hr-mbc-biib021-plus-aromasin-schedule-finding-38812https://curecurrent.com/trials/lapatinib-resistance-in-patients-with-breast-cancer-38813https://curecurrent.com/trials/factors-affecting-decisions-about-breast-reconstruction-after-mastectomy-in-black-and-latina-women-38814https://curecurrent.com/trials/randomized-trial-evaluating-the-effectiveness-of-the-general-practitioner-involvement-in-cancer-screening-invitations-38815https://curecurrent.com/trials/prevention-of-paclitaxel-neuropathy-with-cryotherapy-38816https://curecurrent.com/trials/monitoring-of-neoadjuvant-therapy-in-locally-advanced-breast-cancer-38817https://curecurrent.com/trials/digital-mammography-for-the-detection-and-preoperative-staging-of-breast-cancer-38818https://curecurrent.com/trials/psychosocial-adjustment-after-radiation-therapy-in-patients-with-cancer-38819https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-caelyx-in-combination-with-cyclophosphamide-in-the-treatment-of-metastatic-br-38820https://curecurrent.com/trials/menopausal-symptoms-in-women-with-breast-cancer-or-at-high-risk-of-breast-cancer-treated-on-another-clinical-trial-38821https://curecurrent.com/trials/protexa-versus-tiloopbra-in-immediate-breast-reconstruction-a-pilot-study-38822https://curecurrent.com/trials/lapatinib-and-circulating-tumor-cells-in-breast-cancer-38823https://curecurrent.com/trials/vinorelbine-metronomic-plus-lapatinib-for-overexpressing-her-2-metastatic-breast-cancer-38824https://curecurrent.com/trials/study-of-lapatinib-in-patients-with-relapsed-or-refractory-inflammatory-breast-cancer-38825https://curecurrent.com/trials/kin-keepersm-reducing-disparities-through-cancer-literacy-and-screening-38826https://curecurrent.com/trials/treatment-of-her2-positive-metastatic-breast-cancer-with-herceptin-and-bevacizumab-antibodies-against-her2-and-vegf-38827https://curecurrent.com/trials/long-term-outcome-of-her2-amplified-metastatic-breast-cancer-a-retrospective-analysis-38828https://curecurrent.com/trials/randomized-study-of-combination-chemotherapy-with-or-without-focused-microwave-thermotherapy-before-surgery-in-treating-38829https://curecurrent.com/trials/prospective-non-randomized-evaluation-of-oncoplastic-surgery-38830https://curecurrent.com/trials/bone-geometry-and-muscle-density-changes-in-postmenopausal-women-and-breast-cancer-patients-prescribed-anastrozole-38831https://curecurrent.com/trials/liposomal-doxorubicin-trastuzumab-and-docetaxel-in-her2-positive-metastatic-breast-cancer-38832https://curecurrent.com/trials/effectiveness-and-safety-of-acupuncture-for-climacteric-syndrome-in-patients-with-breast-cancer-38833https://curecurrent.com/trials/development-of-gourmet-healthy-cooking-workshop-for-cancer-patients-38834https://curecurrent.com/trials/epirubicin-and-paclitaxel-alone-or-together-with-capecitabine-as-first-line-treatment-in-metastatic-breast-cancer-38835https://curecurrent.com/trials/trial-comparing-calendula-officinalis-with-aqueous-cream-essex-to-treat-skin-reactions-from-radiotherapy-of-breast-cance-38836https://curecurrent.com/trials/trial-evaluating-the-menstrual-and-ovarian-function-of-young-breast-cancer-patients-treated-with-a-cyclophosphamide-free-38837https://curecurrent.com/trials/a-study-to-assess-the-short-term-efficacy-of-intravenous-ibandronate-bondronat-in-participants-with-metastatic-bone-pain-38838https://curecurrent.com/trials/bkm120-in-cancers-with-pik3ca-activating-mutations-38839https://curecurrent.com/trials/nac-sparing-mastectomy-after-neo-adjuvant-chemotherapy-38840https://curecurrent.com/trials/a-prospective-observational-study-of-clinical-outcomes-for-the-nanostring-technologies-prosigna-gene-signature-assay-38841https://curecurrent.com/trials/accessory-joint-and-neural-mobilizations-in-shoulder-after-breast-cancer-surgery-randomized-clinical-trial-38842https://curecurrent.com/trials/engaging-diverse-underserved-communities-to-bridge-the-mammography-divide-38843https://curecurrent.com/trials/determination-of-autonomic-responses-to-exposure-to-electromagnetic-fields-with-low-energy-modulated-frequency-38844https://curecurrent.com/trials/argon-plasma-coagulation-scalpel-on-surgical-treatment-of-breast-cancer-38845https://curecurrent.com/trials/safety-and-efficacy-study-of-mix-vaccine-in-breast-carcinoma-patient-38846https://curecurrent.com/trials/vinorelbine-gemcitabine-versus-vinorelbine-cisplatin-in-metastatic-breast-cancer-38847https://curecurrent.com/trials/bevacizumab-plus-modified-folfox6-regimen-as-the-salvage-treatment-in-metastatic-breast-cancer-mbc-patients-38848https://curecurrent.com/trials/study-of-biomarkers-associated-with-fatigue-in-patients-with-early-stage-breast-cancer-treated-with-metformin-or-placebo-38849https://curecurrent.com/trials/a-phase-ii-study-of-abraxane-gemcitabine-combination-in-patients-with-metastatic-breast-cancer-38850https://curecurrent.com/trials/study-of-apatinib-in-metastatic-triple-negative-breast-cancer-patients-38851https://curecurrent.com/trials/coagulation-parameters-in-postmenopausal-breast-cancer-patients-under-adjuvant-hormonal-therapy-38852https://curecurrent.com/trials/lux-breast-3-afatinib-alone-or-in-combination-with-vinorelbine-in-patients-with-human-epidermal-growth-factor-receptor-2-38853https://curecurrent.com/trials/the-safety-and-efficacy-of-zoledronic-acid-in-the-prevention-of-cancer-therapy-induced-bone-loss-38854https://curecurrent.com/trials/do-skin-markings-reflect-the-location-of-the-surgical-cavity-during-daily-radiotherapy-treatment-38855https://curecurrent.com/trials/beatrice-study-a-study-of-bevacizumab-avastin-adjuvant-therapy-in-triple-negative-breast-cancer-38856https://curecurrent.com/trials/impact-of-a-group-intervention-on-breast-cancer-patient-s-adjustment-and-emotion-regulation-at-the-end-of-treatment-38857https://curecurrent.com/trials/impact-on-cognitive-function-and-quality-of-life-of-adjuvant-chemotherapy-in-patients-aged-over-65-years-application-to-38858https://curecurrent.com/trials/verbal-and-written-instruction-versus-verbal-and-written-plus-simulation-in-patients-with-breast-cancer-and-their-caregi-38859https://curecurrent.com/trials/gamma-secretase-notch-signalling-pathway-inhibitor-ro4929097-paclitaxel-and-carboplatin-before-surgery-in-treating-patie-38860https://curecurrent.com/trials/quantitation-of-endothelial-progenitor-cells-as-markers-of-tumor-angiogenesis-in-breast-cancer-38861https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-herceptin-trastuzumab-docetaxel-in-patients-with-her2-positive-metast-38862https://curecurrent.com/trials/study-of-neoadjuvant-carboplatin-eribulin-and-trastuzumab-for-operable-her2-positive-breast-cancer-38863https://curecurrent.com/trials/perioperative-use-of-desmopressin-ddavp-in-breast-cancer-38864https://curecurrent.com/trials/a-study-to-determine-the-management-of-palmar-plantar-erythrodysesthesia-ppe-in-patients-with-metastatic-ovarian-or-brea-38865https://curecurrent.com/trials/lapatinib-ditosylate-and-akt-inhibitor-mk2206-in-treating-women-with-metastatic-breast-cancer-38866https://curecurrent.com/trials/safety-and-tolerability-of-different-dose-combinations-of-ridaforolimus-with-mk-2206-or-mk-0752-for-participants-with-ad-38867https://curecurrent.com/trials/oral-deforolimus-with-trastuzumab-for-patients-with-her2-positive-trastuzumab-refractory-metastatic-breast-cancer-8669-0-38868https://curecurrent.com/trials/high-dose-combination-chemotherapy-plus-peripheral-stem-cell-transplantation-in-treating-patients-with-advanced-cancer-38869https://curecurrent.com/trials/a-study-of-trastuzumab-mcc-dm1-administered-intravenously-to-patients-with-her2-positive-metastatic-breast-cancer-who-ha-38870https://curecurrent.com/trials/partial-breast-radiation-therapy-in-treating-women-undergoing-breast-conserving-therapy-for-early-stage-breast-cancer-38871https://curecurrent.com/trials/a-study-of-pertuzumab-in-participants-with-metastatic-breast-cancer-38872https://curecurrent.com/trials/combination-of-carboplatin-eribulin-mesylate-and-e7449-in-brca-related-cancers-38873https://curecurrent.com/trials/computed-tomography-laser-mammography-breast-imaging-device-38874https://curecurrent.com/trials/evaluation-of-a-new-radiotracer-68ga-nota-ae105-for-diagnosing-aggressive-cancer-with-positron-emission-tomography-38875https://curecurrent.com/trials/treatment-of-hot-flushes-in-breast-cancer-patients-with-acupuncture-38876https://curecurrent.com/trials/fulvestrant-vandetanib-in-advanced-aromatase-inhibitor-resistant-breast-cancer-38877https://curecurrent.com/trials/safety-study-of-xl647-and-xl147-administered-in-combination-daily-in-adults-with-solid-tumors-38878https://curecurrent.com/trials/multiple-b-value-diffusion-weighted-imaging-dwi-in-evaluation-of-breast-lesions-38879https://curecurrent.com/trials/a-survey-of-breast-cancer-patients-with-metastatic-bone-disease-receiving-oral-ibandronate-38880https://curecurrent.com/trials/transfected-dendritic-cell-based-therapy-for-patients-with-breast-cancer-or-malignant-melanoma-38881https://curecurrent.com/trials/three-doses-of-tas-108-to-treat-recurrent-or-recurrent-inoperable-breast-cancer-38882https://curecurrent.com/trials/evaluating-and-comparing-two-surgical-methods-for-treatment-of-early-stage-breast-cancer-38883https://curecurrent.com/trials/effectiveness-of-dim-supplements-to-increase-2-ohe1-16-ratio-38884https://curecurrent.com/trials/positron-emission-tomography-pet-using-hormone-receptor-ligands-in-breast-cancer-38885https://curecurrent.com/trials/lean-body-mass-as-a-determinant-of-docetaxel-pharmacokinetics-and-toxicity-38886https://curecurrent.com/trials/the-prevention-of-osteoporosis-in-premenopausal-and-newly-postmenopausal-up-to-8-years-women-with-breast-cancer-followin-38887https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-lapatinib-vinorelbine-in-erbb2-positive-metastatic-breast-cancer-patients-38888https://curecurrent.com/trials/treatment-options-in-human-epidermal-growth-factor-receptor-2-her2-positive-metastatic-breast-cancer-patients-38889https://curecurrent.com/trials/rebecca-research-in-rehabilitation-after-breast-cancer-38890https://curecurrent.com/trials/acupressure-for-persistent-cancer-related-fatigue-38891https://curecurrent.com/trials/vascular-changes-due-to-different-treatments-of-lymphedema-secondary-to-postoperative-breast-cancer-38892https://curecurrent.com/trials/sch-727965-in-patients-with-advanced-breast-and-lung-cancers-study-p04716-38893https://curecurrent.com/trials/neoadjuvant-chemotherapy-in-locally-advanced-breast-cancer-38894https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-high-risk-breast-cancer-38895https://curecurrent.com/trials/kokon-consultation-on-complementary-medicine-in-oncology-a-pilot-study-38896https://curecurrent.com/trials/phase-iii-study-of-atamestane-plus-toremifene-versus-letrozole-in-advanced-breast-cancer-38897https://curecurrent.com/trials/gene-expression-profiling-of-breast-cancer-cells-predict-the-response-of-malignant-pleural-effusion-38898https://curecurrent.com/trials/a-randomised-study-of-docosahexaenoic-acid-dha-in-metastatic-breast-cancer-38899https://curecurrent.com/trials/a-study-on-neoadjuvant-therapy-for-her-2-positive-breast-cancer-and-the-prognosis-by-detecting-ctcs-38900https://curecurrent.com/trials/genetic-polymorphisms-predict-chemotherapeutic-outcomes-in-patients-with-metastatic-breast-cancer-38901https://curecurrent.com/trials/efficacy-and-safety-of-adjuvant-metformin-for-operable-breast-cancer-patients-38902https://curecurrent.com/trials/study-the-role-of-stem-cell-in-curing-drug-induced-liver-injury-in-metastatic-breast-cancer-mbc-38903https://curecurrent.com/trials/role-of-positron-emission-mammography-pem-flex-solo-ii-positron-emission-tomography-pet-scanner-in-evaluating-neoadjuvan-38904https://curecurrent.com/trials/vst-1001-dilute-fluorescein-for-lymphatic-mapping-localization-of-lymph-nodes-in-patients-with-breast-cancer-38905https://curecurrent.com/trials/weight-variation-during-chemotherapy-in-breast-cancer-patients-38906https://curecurrent.com/trials/chemotherapy-monitoring-with-breast-computed-tomography-ct-38907https://curecurrent.com/trials/evaluation-of-the-relationship-of-top2-expression-and-effect-of-non-dose-dense-chemotherapy-for-breast-cancer-38908https://curecurrent.com/trials/perifosine-in-treating-patients-with-recurrent-refractory-locally-advanced-or-metastatic-breast-cancer-38909https://curecurrent.com/trials/gene-expression-profiling-of-metastatic-breast-cancer-predict-the-therapeutic-response-to-chemotherapy-38910https://curecurrent.com/trials/breast-computed-tomography-ct-as-a-diagnostic-tool-38911https://curecurrent.com/trials/study-of-high-dose-chemotherapy-hdc-combined-with-adoptive-cellular-therapy-with-dc-cik-cells-in-triple-negative-breast-38912https://curecurrent.com/trials/vitamin-d3-vit-d3-supplementation-and-t-cell-immunomodulation-in-patients-with-newly-diagnosed-operative-invasive-ductal-38913https://curecurrent.com/trials/study-of-chemotherapy-with-adoptive-cellular-therapy-with-dc-cik-cells-in-triple-negative-breast-cancer-patients-38914https://curecurrent.com/trials/4-hydroxytamoxifen-or-tamoxifen-citrate-in-treating-women-with-newly-diagnosed-ductal-breast-carcinoma-in-situ-38915https://curecurrent.com/trials/electronic-patient-reported-symptom-assessment-38916https://curecurrent.com/trials/safety-study-of-caelyx-in-patients-with-metastatic-breast-cancer-previously-treated-with-anthracyclines-study-p04057-ter-38917https://curecurrent.com/trials/efficacy-of-acupuncture-for-hot-flashes-in-women-treated-with-hormonal-therapy-for-breast-cancer-38918https://curecurrent.com/trials/ddi-study-with-multiple-dose-lx4211-and-single-dose-rosuvastatin-38919https://curecurrent.com/trials/thyroid-dysfunction-in-women-with-newly-diagnosed-breast-cancer-compared-to-healthy-volunteers-38920https://curecurrent.com/trials/staging-of-axillary-lymph-nodes-using-the-pem-flex-solo-ii-pet-scanner-in-patients-with-breast-cancer-38921https://curecurrent.com/trials/lapatinib-for-treatment-of-ductal-carcinoma-in-situ-dcis-of-the-breast-38922https://curecurrent.com/trials/low-dose-metronomic-ldm-chemotherapy-for-metastatic-breast-cancer-38923https://curecurrent.com/trials/study-of-oral-pxd101-in-patients-with-advanced-solid-tumors-or-lymphoma-38924https://curecurrent.com/trials/study-of-pxd101-alone-and-in-combination-with-5-fluorouracil-5-fu-in-patients-with-advanced-solid-tumors-38925https://curecurrent.com/trials/quantitative-dynamic-contrast-enhanced-breast-mri-38926https://curecurrent.com/trials/pet-mr-for-prediction-and-monitoring-of-response-to-neoadjuvant-chemotherapy-in-breast-cancer-38927https://curecurrent.com/trials/spousal-relationships-and-pain-in-metastatic-breast-cancer-38928https://curecurrent.com/trials/body-image-and-psychosocial-functioning-in-women-with-breast-cancer-can-we-fix-what-we-ve-broken-38929https://curecurrent.com/trials/prognostic-value-of-divpenia-and-cd4-count-in-relapsed-breast-or-lung-cancer-patients-38930https://curecurrent.com/trials/screening-mammography-and-latinas-a-multilevel-intervention-38931https://curecurrent.com/trials/decision-aids-for-tamoxifen-treatment-in-breast-cancer-patients-38932https://curecurrent.com/trials/a-study-to-evaluate-erlotinib-in-patients-with-advanced-or-metastatic-breast-cancer-during-or-following-chemotherapy-38933https://curecurrent.com/trials/magnetic-resonance-imaging-in-patients-with-breast-cancer-38934https://curecurrent.com/trials/mindfulness-and-cancer-mamma-clinical-trial-mbsr-among-women-operated-for-breast-cancer-38935https://curecurrent.com/trials/exemestane-with-celecoxib-as-neoadjuvant-treatment-in-postmenopausal-women-with-stage-ii-iii-and-iv-breast-cancer-38936https://curecurrent.com/trials/comparative-evaluation-of-osteopathy-treatment-efficacy-in-pain-support-after-breast-surgery-in-oncology-38937https://curecurrent.com/trials/evaluation-of-accelerated-partial-breast-brachytherapy-38938https://curecurrent.com/trials/understanding-patient-perspectives-on-the-risks-of-ionizing-radiation-used-for-medical-imaging-38939https://curecurrent.com/trials/safety-and-efficacy-study-of-femara-letrozole-as-an-extended-adjuvant-treatment-in-breast-cancer-patients-38940https://curecurrent.com/trials/phase-1-2-study-of-onapristone-in-patients-with-progesterone-receptor-expressing-cancers-38941https://curecurrent.com/trials/hybrid-simulation-in-teaching-clinical-breast-examination-38942https://curecurrent.com/trials/safety-study-of-imexon-plus-docetaxel-in-lung-breast-or-prostate-cancer-patients-38943https://curecurrent.com/trials/validation-of-a-mouse-model-of-pancreatic-carcinogenesis-38944https://curecurrent.com/trials/promoting-a-healthier-lifestyle-among-breast-cancer-survivors-38945https://curecurrent.com/trials/validation-of-70-gene-mammaprint-profile-in-japanese-population-38946https://curecurrent.com/trials/suppression-of-bone-turnover-following-treatment-with-zoledronic-acid-in-patients-with-metastatic-breast-cancer-duration-38947https://curecurrent.com/trials/safety-study-of-radiation-and-cp-675-206-infusion-for-breast-cancer-patients-38948https://curecurrent.com/trials/allogenic-haematopoietic-cell-transplantation-for-patients-with-refractory-triple-negative-breast-cancer-38949https://curecurrent.com/trials/clinical-application-of-near-infrared-fluorescence-guided-localization-on-breast-surgery-in-benign-breast-neoplasm-38950https://curecurrent.com/trials/clinical-utility-of-ctc-test-in-medicare-eligible-metastatic-breast-cancer-patients-38951https://curecurrent.com/trials/clinical-application-of-near-infrared-fluorescence-guided-localization-on-breast-surgery-in-breast-cancer-38952https://curecurrent.com/trials/alkaline-water-in-reducing-skin-toxicity-in-women-with-breast-cancer-undergoing-radiation-therapy-38953https://curecurrent.com/trials/reducing-breast-cancer-recurrence-with-weight-loss-38954https://curecurrent.com/trials/manual-lymphatic-drainage-in-the-superior-member-in-women-in-post-surgery-for-breast-cancer-38955https://curecurrent.com/trials/decision-support-workshop-for-breast-reconstruction-38956https://curecurrent.com/trials/tailored-web-based-intervention-for-cancer-patients-and-family-caregivers-38957https://curecurrent.com/trials/multimedia-educational-program-for-patients-with-early-stage-prostate-cancer-or-breast-cancer-38958https://curecurrent.com/trials/activated-allogeneic-lymphocytes-for-induction-graft-versus-tumor-effect-in-metastatic-solid-tumors-38959https://curecurrent.com/trials/neural-stem-cell-preserving-brain-radiation-therapy-stereotactic-radiosurgery-in-patients-with-1-6-brain-metastases-38960https://curecurrent.com/trials/does-watercress-intake-have-an-impact-on-cancer-patients-outcomes-a-longitudinal-trial-38961https://curecurrent.com/trials/comparative-efficiency-of-three-regimen-cefci-cef-and-ec-as-neoadjuvant-chemotherapy-for-primary-breast-cancer-38962https://curecurrent.com/trials/study-of-exercise-to-manage-distress-during-breast-screening-38963https://curecurrent.com/trials/study-of-barriers-to-beginning-and-finishing-treatment-for-patients-with-breast-cancer-38964https://curecurrent.com/trials/mindful-movement-program-in-improving-quality-of-life-in-older-female-breast-cancer-survivors-38965https://curecurrent.com/trials/ih636-grape-seed-extract-in-preventing-breast-cancer-in-postmenopausal-women-at-risk-of-developing-breast-cancer-38966https://curecurrent.com/trials/lbh589-in-combination-with-capecitabine-plus-minus-lapatinib-in-breast-cancer-patients-38967https://curecurrent.com/trials/hypofractionated-radiotherapy-post-lumpectomy-in-women-with-node-negative-breast-cancer-38968https://curecurrent.com/trials/white-button-mushroom-extract-in-preventing-the-recurrence-of-breast-cancer-in-postmenopausal-breast-cancer-survivors-38969https://curecurrent.com/trials/breast-conserving-therapy-in-patients-with-triple-negative-breast-cancer-38970https://curecurrent.com/trials/bilingual-breast-cancer-educational-intervention-for-hispanic-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-and-38971https://curecurrent.com/trials/pilot-study-of-secondary-causes-of-osteopenia-osteoporosis-in-adults-with-breast-and-prostate-cancer-38972https://curecurrent.com/trials/strength-training-study-for-survivors-of-breast-and-gynecologic-cancer-38973https://curecurrent.com/trials/study-of-support-groups-for-african-american-breast-cancer-survivors-38974https://curecurrent.com/trials/exercise-training-in-postmenopausal-patients-with-breast-cancer-38975https://curecurrent.com/trials/nimotuzumab-plus-docetaxel-and-capecitabine-versus-docetaxel-and-capecitabine-in-the-treatment-of-breast-cancer-patients-38976https://curecurrent.com/trials/a-non-interventional-study-with-doce-onkovis-docetaxel-utilized-for-the-treatment-of-cancer-38977https://curecurrent.com/trials/synergistic-effect-of-ibuprofen-and-hydromorphone-for-postoperative-pain-38978https://curecurrent.com/trials/vibro-acoustography-imaging-in-diagnosing-breast-masses-in-women-with-a-breast-mass-or-breast-cancer-38979https://curecurrent.com/trials/safety-study-of-cancer-stem-cell-vaccinie-to-treat-breast-cancer-38980https://curecurrent.com/trials/2-weeks-of-adjuvant-radiotherapy-in-patients-with-breast-cancer-38981https://curecurrent.com/trials/a-comparison-of-breast-tomosynthesis-mammography-and-conventional-breast-imaging-in-the-characterization-of-breast-masse-38982https://curecurrent.com/trials/horse-chestnut-seed-extract-for-lymphedema-38983https://curecurrent.com/trials/step-by-step-a-tailored-walking-intervention-for-breast-cancer-survivors-38984https://curecurrent.com/trials/promoting-breast-cancer-screening-in-non-adherent-women-38985https://curecurrent.com/trials/partial-breast-irradiation-with-multi-catheter-brachytherapy-for-pt1-2pn0-breast-cancer-after-breast-conserving-surgery-38986https://curecurrent.com/trials/studying-tumor-tissue-samples-from-patients-with-early-stage-breast-cancer-38987https://curecurrent.com/trials/vinorelbine-metronomic-plus-bevacizumab-as-salvage-therapy-for-breast-cancer-38988https://curecurrent.com/trials/cancer-mortality-affected-by-the-choice-of-anesthetic-drugs-38989https://curecurrent.com/trials/intensive-combo-chemo-with-autologous-bm-rescue-for-metastatic-breast-cancer-38990https://curecurrent.com/trials/capecitabine-vs-s-1-in-unresectable-or-recurrent-breast-cancer-38991https://curecurrent.com/trials/optimizing-body-composition-health-after-breast-cancer-38992https://curecurrent.com/trials/strength-training-for-older-breast-cancer-survivors-38993https://curecurrent.com/trials/level-up-video-games-for-activity-in-breast-cancer-survivors-38994https://curecurrent.com/trials/cognitive-behavioral-therapy-for-chronic-insomnia-after-breast-cancer-treatment-38995https://curecurrent.com/trials/oral-health-and-oral-health-related-quality-of-life-in-early-stage-breast-cancer-survivors-38996https://curecurrent.com/trials/a-pilot-study-of-working-women-and-breast-cancer-38997https://curecurrent.com/trials/ro4929097-and-exemestane-in-treating-pre-and-postmenopausal-patients-with-advanced-or-metastatic-breast-cancer-38998https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-plus-taxane-based-therapy-in-patients-with-locally-recurrent-or-metastatic-breast-cancer-38999https://curecurrent.com/trials/neoviderm-skin-emulsion-in-the-prevention-of-radiation-dermatitis-39000